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Abstract 
The current standards for whole-brain in vivo imaging cannot provide the cellular resolution and 
neuron stimulation needed to study neuronal plasticity, important in memory formation. Current in vivo 
studies of neuronal dynamics are limited to animal models, due to deleterious effects resulting from the 
application of fluorophores. Nanoparticle (<100nm) quantum dots (QDs) are a promising alternative to 
traditional fluorophores because they are bright, photostable, and have highly tunable spectra, making 
them appropriate for a variety of applications. Furthermore, previous studies have shown that QDs have 
properties that can elicit electrical activity in neurons. Scientists at the University of Nova Gorica in 
Slovenia are studying this interaction. To help advance this research, we designed a perfusion system to 
deliver drugs and QDs to cultures of rat hippocampal neurons. This perfusion system successfully 
delivered Gabazine, Tetradotoxin, and QDs to the culture, blocked ambient light during imaging, limited 
mounting time, was easy to manufacture, and was cost effective. Using this device in conjunction with 
calcium imaging techniques, we demonstrated that the mechanism of interaction between carboxyl-
coated QDs and hippocampal neurons is localized to the synapse, producing synchronous electrical 
activity.  
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1 Introduction 
A neuron sits on a small glass slide, bombarded with intense blue light and shining back with 
green fluorescent shine. With a sudden change in the concentration of calcium ions inside the cell, there 
is a flash of green brilliance. The random waves of electrical activity in the isolated neuron trigger a 
transient release of chemicals. When one neuron grows next to another, however, they physically 
connect, and engage in patterned and synchronized waves of electrical and chemical activity.  
Human beings possess 86 billion synchronously communicating neurons, held together in a 
single three-pound mass (Azevedo F. A., et al., 2009). The human brain may be the most complex living 
network of any kind in the known universe. This level of detail and complexity has scientists working 
across the globe to develop technologies with sufficient resolution and throughput to map the entire 
brain: from cell, to system, to thought. 
The public demand to understand neuroscience is also apparent; in 2004 alone, the total cost of 
treatment for nervous system disorders across Europe was €447 billion (Andlin‐Sobocki, 2005). For 
instance, when the hippocampus is destroyed on both sides of a mammal’s brain, the ability to form 
new memories is largely lost (Johnston, 2004). Thus, the neurons in this region of the brain have come 
under scrutiny in order to better understand neural plasticity, the ability to form new memories 
(Wiocur, Wojtowicz, Sekeres, Snyder, & Wang, 2006). The hippocampus has a simple structure, 
consisting of a single folded layer of neurons. Additionally, genetic mutations in hippocampal neurons 
have been linked to epilepsy (Alberts, 2008), a chronic condition in which synchronous firing of neurons 
in the hippocampus causes dramatic seizures.  
There are currently several gold standard methods used to study neuron signaling, which gather 
information at the level of both the individual neuron and at the level of the overall brain structure. 
Techniques have been applied to both in vitro samples and living subjects. However, there is no 
technology that exists capable of bridging these levels. In vitro cultures are generally studied with patch 
clamping, the Nobel Prize winning electrophysiological method that directly measures the electrical 
activity in cells and tissue slices. Patch clamping recordings can be varied in scale from a single pore in a 
membrane to the overall voltage in the cell culture. The method, though, cannot be used in vivo, due to 
physical limitations of the large electrodes in a small space (Hamill, Marty, E, B, & J, 1981). With 
increasing complexity in the brain, fluorescent dyes are used to reveal the waves of calcium oscillations 
among groups of cells. Calcium levels are reliable and indirect indicators of electrical activity in neurons 
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(Innocenti, Parpura, & Haydon, 2000). Fluorescent in vivo imaging has even been pioneered using dyes 
that require radiation from two photons of light to simultaneously strike a target molecule, limiting the 
chance background particles shining into the focal plane (Stosiek, Garaschuk, & Holthoff, 2003). Finally, 
conscious and subconscious mental activity can be studied using fMRI. This technique measures the 
different magnetic responses of oxygenated and deoxygenated blood in the brain, resulting in an 
effective map of brain activity (Logothetis, Pauls, Augath, & Trinath, 2001). However, fMRI offers 
insufficient spatial and temporal resolution, which impacts the ability to record transient signals. 
Nanoparticle Quantum Dots (QDs) are a promising alternative that may one day unite the many 
facets of neuroscience, due to their unique optical and electrical properties. Their bilayer crystalline 
structure consists of a metallic core and ceramic coating, which combine to impart fluorescent and 
electrical properties to the particle. Optically, QDs are much brighter than traditional fluorescent dyes. 
These particles are resistant to photobleaching, or fading over time, and also have a higher optical 
efficiency than these dyes, reemitting a large percentage of the energy they absorb as light (Murphy, 
2013). Additionally, QDs have tunable properties, depending on the size of the core, which dictate the 
color at which the QDs emit light, allowing for unique experimental approaches (Murphy, 2013). 
Electrically, QDs have shown the ability to interact with neurons. Specifically, certain types of 
QDs dramatically modify the characteristics of action potentials, the electrochemical signals that 
neurons use to rapidly transmit signals (Zhao, Xu, Zhang, Ren, & Yang, 2009). The frequency and pattern 
of action potentials determines the information sent from one neuron to the next. Zinc-Oxide QDs 
embedded in a polymer matrix have been shown to increase both the frequency and duration of action 
potentials in neurons (Lugo, Miao, Rieke, & Lin, 2012). The efforts to bridge the different levels of 
neuroscience are global in scale. In addition to efforts by Lugo et al in Seattle, USA, researchers at the 
University of Nova Gorica (UNG) in Slovenia are studying the effects of Zinc-Sulfide shelled, Cadmium 
Selenium core QDs on rat hippocampal neurons. Dr. Giulietta Pinato has noted that in vitro application 
of QDs to a culture of hippocampal neurons causes synchronous action potentials in the culture. At 
UNG, researchers are conducting experiments to learn more about the interaction between QDs and 
hippocampal neurons.  
These experiments were completed at the newly renovated Centre for Biomedical Sciences and 
Engineering in the town of Vipava, Slovenia. This relatively new laboratory offers many opportunities for 
improvements to both the available equipment and techniques used. Dr. Pinato’s experiments have 
proven to be time and labor intensive, due in part to a handmade and highly variable perfusion system, 
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used to supply various concentrations of molecules to neural cultures during calcium imaging. The goal 
of our project was to design and build a device that rapidly removes unwanted material from the 
culture, blocks ambient light from the microscope, minimizes the use of expensive test materials, and 
increases both ease-of-use and consistency. This device was created using mostly available parts and at 
a total cost of less than €20 ($30). Simultaneously, the team furthered Dr. Pinato’s research into the 
electrical interactions of various CdSe-ZnS QDs with hippocampal cells. After the seven-week project, 
the students presented their research findings and new device to UNG sponsors and Worcester 
Polytechnic Institute advisors. 
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2 Background 
The University of Nova Gorica’s (UNG) Centre for Biomedical Sciences and Engineering is a newly 
opened research campus in Vipava, Slovenia. Researchers at this Centre need accurate and inexpensive 
ways to advance their current research. This section describes the important requisite information 
needed to understand the research efforts in neuroscience and nanoparticles at the Centre. This chapter 
first portrays the societal, clinical, and research significance of neuroscience. Particular emphasis is 
placed on current methods and techniques used to measure the physiological processes of the brain. 
Next, a background in neuroscience is provided, detailing physiological signaling events in the 
hippocampus, then in groups of neurons, and finally, single cells. At this level, electrical activity of 
hippocampal neurons can be stimulated and synchronized by nanoscale particles called Quantum Dots 
(QDs). We will outline the state of the art to study QDs and neurons simultaneously, with particular 
emphasis on fluorescence microscopy. With fluorescence microscopy, QDs can be visualized 
simultaneously with calcium ions in the cell, by use of dyes that change with ion concentration. 
Fluorescence microscopy is often performed with a perfusion system on the microscope that delivers 
test solutions to the culture, used in this case to characterize neural activity.  
 
2.1 Clinical & Research Significance of Neuroscience 
Diseases affecting the brain are common causes of medical problems across the world, with the 
cost of treatment for brain-related illnesses in 2004 in Europe amounting to €447 billion (Andlin‐
Sobocki, 2005). The cost is due in part to the incredible complexity of the brain. With 86 billion neurons, 
each with approximately 1000 connections, the human brain is a higher-order labyrinth that, to this day 
confounds the biggest super-computers and most intelligent scientists (Azevedo F. , et al., 2009).  
However, significant progress has been made to map the activities of the brain from cell, to 
system, to thought, in order to better understand and treat brain disorders. The history and success of 
neuroscience is a result of many specific techniques, ranging from single-cell electrodes, to ion 
measurements across many cells, and on to whole brain scans of anatomy and mental activity. Uniting 
these aspects of neuroscience will be crucial to develop treatments for neurological problems. 
It is possible to directly measure the electrical activity of a single neuron. In 1981, Robert Keher 
published a novel technique, called patch clamping, which revolutionized the understanding of the 
brain. This technique allowed, for the first time, direct measurements of the electrical properties of a 
single pore in the plasma membrane, further elucidating the mechanisms by which neurons are able to 
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transfer electrical information. Ten years later, Keher was awarded a Nobel Prize for his work. For many 
years, this technique provided significant insight into neuronal function. However, because the 
technique requires the precise placement of relatively large pipettes and electrodes in a small culture, 
there is a limit to the number of simultaneous recordings (Hamill, Marty, E, B, & J, 1981).  
At the next level, fluorescent imaging is used to infer information about the electrical activity of 
neurons. Commonly, the dye Oregon Green BAPTA (OGB) is used, which fluoresces brighter when bound 
to calcium ions (Bootman, Reitdorf, Walker, & Sanderson, 2013). As a neuron generates an electrical 
signal, the change in intensity of light from the dye can be detected under a microscope and measured.  
Currently, calcium imaging using dyes has been expanded to in vivo environments, using a two-
photon system. In this approach, the fluorescent dye responsible for the calcium signaling needs the 
simultaneous energy of two photons of light striking it at once in order to reemit one photon of longer-
wavelength light (Stosiek, Garaschuk, & Holthoff, 2003). Studies have shown that in vivo Fluorescent 
Resonance Energy Transfer (FRET) imaging has been used effectively with QDs (Ingram & Zhang, 2013).  
At the highest levels of brain function, functional Magnetic Resonance Interference (fMRI) 
imaging and Positron Emission Tomography (PET) scans are used to map the activity of the overall brain. 
fMRI uses the ratio of the magnetic resonances, a unique molecular property, of oxygenated and 
deoxygenated hemoglobin in the brain to better understand the metabolic activity of the brain. fMRI 
does not require the injection of dyes or stains into the body, but the procedure does lack spatial and 
temporal resolution (Logothetis, Pauls, Augath, & Trinath, 2001). PET, by contrast, uses an injected 
positron-emitting radionuclide tracing material to track particles in the brain. Oftentimes, PET 
radionuclides are conjugated to a glucose analog that allows scientists and doctors to track metabolic 
activity (Cheng, et al., 2006). 
 
2.2 Neurobiology 
UNG researchers tasked the team to investigate the relationship between quantum dots and 
hippocampal neurons, a type of brain cell. In order to investigate the electrophysiological interaction, it 
was first necessary to understand the biological functioning of the hippocampus itself and related 
cellular processes. 
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2.2.1 The Hippocampus 
The hippocampus is part of the limbic system and is a target for stress hormones. This region of 
the brain resides in the medial temporal lobe of the brain, underneath the cerebral cortex, as seen in 
Figure 1 (McEwen, 1999). The hippocampus is composed of two sheets of neurons folded onto each 
other, taking the shape of a seahorse (Bear, Connors, & Paradiso, 2007). This relatively simple physical 
organization, as compared to other sections of the brain, makes the hippocampal region ideal for 
studying synaptic transmission (Bear, Connors, & Paradiso, 2007). 
 
 
Figure 1: The hippocampus, a region of the brain known to play a role in memory formation 
 
The neurons in this region of the brain have come under scrutiny in order to better understand 
neural plasticity (Wiocur, Wojtowicz, Sekeres, Snyder, & Wang, 2006). Plasticity is the ability of neurons 
to change and form new connections with other neurons. It is related to the rate at which neurons fire 
action potentials, which varies depending on the magnitude and duration of stimulation. Plasticity 
causes changes in the expression of genes, which encode for receptors on the cell membrane of 
neurons. Moreover, neurons can atrophy from over-stimulation due to hormones and loose physical 
connections with their neighbors (McEwen, 1999). This ability for neurons to adapt their physical 
synaptic connection is thought to play an important role in the formation of memory.  
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2.2.2 Neurons and Neuronal Cells 
Hippocampal plasticity results from two neurons interacting and changing the frequency or 
duration of their electrical activity. Neurons require a highly controlled extracellular environment to 
effectively transmit signals. By themselves, neurons are not capable of regulating the entire brain. The 
other cells of the brain are collectively called glial cells. In mammals, glial cells are distinct from typical 
neurons in that they are able to continuously divide and reproduce over the lifetime of an organism 
(Eriksson, 1998). From the Greek word ‘glue’, glial cells serve as supporting cells for neurons, fulfilling 
four main functions; (1) providing structural support for neurons, (2) supplying neurons with nutrients 
and oxygen, (3) insulating the axons and dendrites of neurons for more efficient signaling, and (4) 
phagocytizing, or ingesting and destroying, pathogens and dead neurons. 
There are several glial cell types, which vary in function and morphology. The most notable 
types of glia are astrocytes, oligodendrocytes, and microglia (Haydon, 2001). Astrocytes, seen in Figure 
2, are the primary supporting cells in the brain, possessing numerous branches that extend away from 
the neuron cell body. Dendrites regulate the extracellular chemical environment of neurons. Astrocytes 
recycle neurotransmitters from the synapse to minimize the delay between action potentials, as well as 
remove excess ions, notably potassium, from the extracellular environment (Haydon, 2001). Astrocytes 
have been shown to exhibit calcium signaling when a messenger molecule, IP3, is released into gap 
junctions between neighboring cells. IP3s release stimulates a calcium wave that propagates from cell to 
cell, although this wave is distinct from action potentials (Innocenti, Parpura, & Haydon, 2000). 
Oligodendrocytes are cells that insulate the axons of neurons to increase the efficiency of electrical 
signaling in action potentials (Haydon, 2001). Microglia are highly specialized macrophages that are 
capable of phagocytosis in the central nervous system. These are active even in the healthy brain tissue, 
clearing undesirable dead neurons and pathogens that have intruded into the brain’s environment 
(Ballabh, Braun, & Nedergaard, 2004). 
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Figure 2: A cartoon schematic of a human astrocyte cell; A supporting cell that regulates neurotransmitters and ion 
concentrations outside neurons. Note the numerous branches that extend from the neuron cell body. Astrocytes exhibit 
calcium waves, but do not propagate action potentials. 
 
It is important to identify glial cells of in vitro cultures when studying the brain, as they do not 
have the ability to fire action potentials, but still exhibit waves of calcium signals as a form of secondary 
messaging. Thus, glial cells have electrophysiological properties of their own and contribute to the 
calcium ion flux of neural networks. These properties result in many artifacts during calcium imaging 
that might be identified as neurons without concurrent visualization with conventional bright field 
imaging. Overall, the magnitude of calcium transients during wave propagation in astrocytes is not as 
great as calcium transients in action potentials. They produce smaller, but detectable, signals during 
calcium imaging, which may be confused with the calcium signals of action potentials. (Fields & Stephen-
Graham, 2002). 
 Neurons are the most basic cells of the nervous system, which can be separated into three 
categories: sensory, motor, and interneurons. Despite their different functions, most neurons are 
comprised of the same four components: the cell body, the axon, the dendrites, and the synapse, as 
seen in Figure 3.  
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Figure 3: Structure of a neuron; Axons carry information from one cell body to the dendrites of another, allowing cells to 
communicate. Adapted from (Alberts, 2008) 
 
The soma, or cell body, is the roughly spherical center of the neuron. It is about 20μm in 
diameter and houses the nucleus (Bear, Connors, & Paradiso, 2007). The dendrites are finger-like 
extensions of the cell body that extend to neighboring neurons. Dendrites essentially function as a 
neuron’s antenna, receiving signals from neighboring cells (Bear, Connors, & Paradiso, 2007).  On one 
side of the cell body, the axon extends to reach other neurons. The axon is uniquely responsible for 
sending information over long distances. The beginning of the axon, connected to the cell body, is called 
an axon hillock; this is where an action potential begins. Axons may either branch or remain a single 
conduction path; regardless, each axon branch ends with a synapse, which connects to nearby dendrites 
(Bear, 38). The release of neuron-specific signaling molecules, called neurotransmitters, from the 
synapse causes the proliferation of action potentials in the brain. 
A synapse is the junction between two cells across which neurons transmit action potentials. 
Action potentials are all-or-nothing chain reactions that proceed down the length of the axon. Two types 
of neurotransmitters play roles in passing along action potentials to post-synaptic cells, as seen in Figure 
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4. Neurotransmitters cause either excitatory postsynaptic potentials (EPSPs), if neurotransmitters elicit 
the flow of positive ions, or inhibitory postsynaptic potentials (IPSPs), if neurotransmitters elicit the flow 
of negative ions. If the sum of the EPSPs minus the sum of the IPSPs is greater than the action potential 
threshold, then the action potential is transferred across the synapse to the neighboring cell (Johnston, 
2004). 
 
 
Figure 4: Structure and function of a neuron synapse; Information is carried from one neuron to another in the form of 
neurotransmitter chemicals. The terms ‘presynaptic’ and ‘postsynaptic’ refer to the transmitting and receiving cells, 
respectively. Adapted from (Alberts, 2008) 
 
The neurotransmitters acetylcholine, glutamate, and serotonin usually evoke the EPSP response 
by opening the transmitter-gated cation channels in synapses, while the presence of gamma-
Aminobutyric acid (GABA) or glycine evokes the IPSP response by opening transmitter-gated anion 
channels (Alberts, 2008). Cations are positively charged ions, such as sodium, potassium, or calcium, 
while anions are negatively charged ions, such as chlorine. GABA is the primary IPSP neurotransmitter in 
the mammalian central nervous system, causing a reduction in the frequency and duration of action 
potentials. 
Gabazine is a frequently used drug in scientific research that blocks the activation of GABA-
mediated neurotransmitter receptors in the synapse. Gabazine is an anti-IPSP drug that prevents the 
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opening of anion channels that normally inhibit action potentials in the post-synaptic cell. Thus, 
Gabazine cancels out all inhibition in synapses, causing frequent and synchronous action potentials 
(Lüscher & Keller, 2004).  
 
2.2.3 Action Potentials and Calcium Ions 
Most organisms possess the ability to rapidly respond to external optical, physical and chemical 
stimuli in their environment. Sensory neurons receive and translate these signals into electrical 
information, called action potentials, which are quickly conveyed throughout the organism. Action 
potentials are localized, temporary changes in the concentrations of cations and anions around neurons. 
When there is no net movement of ions across the membrane, the membrane is said to be in 
equilibrium. The electrical potential of a neuron is -70mV, commonly referred to as the resting potential. 
The negative sign comes from the convention to subtract the external potential, which is usually 
positive, from the internal potential, which is usually negative (Cooper & Hausman, 2013). This 
electrochemical potential is the tendency for ions to move across a cell membrane when an ion channel 
opens. A single neuron might typically contain 10 or more different types of ion channels, located in 
different regions of its plasma membrane (Alberts, 2008). 
The electrical activity at any one spot on the axon during an action potential can be visualized on 
a graph similar to Figure 5, with the x-axis representing time in milliseconds (msec) and the y-axis 
representing membrane potential in millivolts (mV).  
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Figure 5: Visualization of the membrane potential during an action potential; (1) resting membrane potential, (2) the rising 
stage, or depolarization, when sodium flows into the cell, (3) hyperpolarization, when cytosol is more positive than 
extracellular environment, (4) falling phase, or repolarization, when potassium slowly resets, (5) refractory, or rest, period  
 
The first part of the action potential is called the rising phase, or depolarization; it correlates 
with the rapid influx of positive sodium ions into the cell and corresponds with (2) in Figure 5. This 
positive feedback loop continues until the local plasma membrane potential has shifted from a resting 
value of -70mV to +50mV, almost the sodium equilibrium potential (Alberts, 2008). The peak of the 
spike at (3) is when the inside of the cell is more positive than the outside, also referred to as 
hyperpolarization (Bear, 82). The falling phase at (4), or repolarization, follows hyperpolarization and is 
characterized by the slow movement of potassium ions out of the cell (Alberts, 2008).  The action 
potential lasts roughly 2ms and ends with the neuron returning to resting potential at -65mV. A relative 
refractory period of approximately 1ms is the time it takes for a neuron to be ready to conduct another 
action potential.   
In equilibrium, the concentration of sodium ions is about 30 times greater outside the cell than 
inside, with the reverse being true for potassium ions (Alberts, 2008). Sodium ion channels have the 
benefit of efficiency; up to 100 million ions can pass through a channel per second, allowing for high 
signaling frequency (Alberts, 2008). However, sodium moves too fast in neurons to be accurately 
resolved with modern research-grade cameras and microscopes. The use of calcium ions as indicators is 
much more effective to infer electrical activity for three reasons (Alberts, 2008). First, transient 
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movement of calcium ions across the membrane is relatively slow (10-100ms) compared to fast-
activating sodium ions. Second, calcium ion fluctuations are monotonic, meaning every action potential 
elicits a corresponding change in calcium concentration inside the cell. Third, there are 1000 times more 
calcium ions in the extracellular matrix than in the cytosol of the neuron. As a result, calcium ions are 
often used as indicators for action potentials in cells, as seen in Figure 6, because even a small influx of 
calcium ions into the can elicit action potentials (Alberts, 2008). 
 
 
Figure 6: Hippocampal neurons stained with intracellular Oregon Green BAPTA (OGB) dye, which fluoresces brighter when 
bound to calcium, such as during action potentials.  
 
When neurons are immersed in fluorescent Oregon Green BAPTA (OGB) dye, the dye permeates 
the plasma membrane and undergoes a conformational change that renders OGB membrane-
impermeable. In this way, the dye accumulates on the inside of the cell. When calcium rushes into the 
cell, it binds to OGB and causes the dye to fluoresce brighter, similarly to an action potential. Thus, 
calcium-bound OGB can be used to effectively determine action potential signaling. 
 
2.3 Quantum Dots 
Modern biology requires scientists to visualize and understand molecular interactions, which are 
difficult to measure in vivo. One of the most promising avenues of sub-cellular imaging is QD-based 
fluorescence microscopy. When the electrons in a semiconductor are excited, they tend to remain at a 
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certain fixed distance from positive charges, called the excitation radius. QDs are 10-50nm diameter 
fluorescent nanoparticles that exhibit semiconductor capabilities. Their semi-conductive properties 
allow the dots to switch rapidly between states of highly conductive and highly insulative properties 
(Michalet, et al., 2005). 
 
 
 
Figure 7: The structure of a Qdot® 655 ITK by Invitrogen, Life Technologies. Adapted from (Qdot Nanocrystals—Section 6.6) 
 
Quantum Dots consist of three layers: the core, shell, and polymer coating. This coating is often 
conjugated with biomolecules that change the way QDs interact with cells, as seen in Figure 7. At UNG, 
research is focused on the CdSe-core, ZnS-shelled QDs with polyethylene-glycol (PEG) coatings used to 
minimize toxic effects by reducing the amount of heavy metals exposed to living tissue (Hardman, 2006). 
Additional functional groups can be conjugated to the polymer coating, namely carboxyl groups and 
streptavidin groups. Carboxyl groups are highly reactive, allowing QDs to be conjugated with a variety of 
materials. These QDs can be seen in Figure 8. 
 
 15 
  
 
Figure 8: Hippocampal neuron with Carboxyl-coated QDs, shown in red, attached to its surface of the neuron. OGB bound to 
calcium, green, indicates the location of the neuron 
 
Streptavidin is a biomolecule that has a high specificity for biotin molecules. Biotin molecules 
easily conjugate with most antibodies, allowing for specific molecule tracking and highly specific cell 
targeting (Howarth, Takao, Hayashi, & Ting, 2005). For example, QDs have shown the ability to fluoresce 
through up to 10mm of living tissue when targeted to cancer tumors in mice (Gao, 2004). 
 
2.3.1 Optical Properties 
Fluorescence is the emission of photons by atoms or molecules whose electrons have been 
excited to a higher energy state by radiation. The excited electrons almost immediately fall back to the 
lower energy states. In the process, electrons release the potential energy as either heat or as another 
photon of light (Murphy, 2013). Fluorescence microscopy uses this principle to resolve incredibly fine 
molecules, such as QDs, that would typically not be visible under a microscope, therefore allowing the 
distribution of a single molecular species to be visualized. 
One of the most significant limiting factors in fluorescence microscopy with traditional 
fluorescent molecules, or fluorophores, is the effect of photobleaching, also known as fading. This 
phenomenon occurs when a fluorophore loses the ability to fluoresce, due to chemical damage or 
covalent modification. This causes a degradation in signal intensity over the course of imaging, as more 
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molecules become damaged (Murphy, 2013). QDs are incredibly resistant to photobleaching and can be 
tracked for long periods of time with no degradation in signal (Lacoste, et al., 2000). 
Fluorescent molecules absorb photons of light at shorter wavelengths and emit photons of light 
at longer wavelengths (Murphy, 2013). The absorbance and emission peaks are never sharp, but rather 
are comprised of ranges of wavelengths, known as spectra. A graph of the excitation and emission 
wavelengths of eight different QD conjugates can be seen in Figure 9.  
 
 
Figure 9: The excitation and emission spectrum of CdSe-ZnS Qdots® by Invitrogen, Life Technologies. Adapted from (Qdot 
Nanocrystals—Section 6.6) 
 
The difference between the peaks in the absorbance and emission spectra is known as the 
Stokes shift. QDs have a remarkably wide and adaptable Stokes shift (Murphy, 2013). A large Stokes shift 
translates to more resolution in fluorophores, because the wavelength of light used to excite molecules 
is well separated from the wavelength of light used to record the signal. The size of the core of QDs 
dictates the emission spectral profile, with cores of sizes as small as 2nm emitting in the blue 
wavelengths of light, and larger cores of sizes 5-7nm emitting in the yellow and red wavelengths of light 
(Murphy, 2013). In practical terms, this means that smaller particles are harder to excite and produce 
more bluish light, while larger particles are easier to excite and produce more reddish light (Alivisatos, 
1996). The emissions spectrum of QDs is remarkably symmetrical and exhibits large quantum efficiency 
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values in almost any medium, meaning they reemit a greater proportion of absorbed photons than 
typical fluorophores.  
UNG currently uses a Quantum Dot called Qdot-655 by Invitrogen, a division of Life Sciences. 
The Qdot-655 has an absorption spectrum ranging from below 400nm up to 750nm, and an emission 
spectrum ranging from 600nm to 700nm. Sometimes, when a QD is excited by radiation, a temporary, 
local voltage can form in the area, otherwise known as a dipole moment. This unique property has 
produced innovative research exploring the use of QDs to stimulate electrical activity in neurons. 
 
2.3.2 Electrical Properties 
Quantum dots can be used to stimulate and intentionally trigger action potentials. The dipole 
moment of QDs is understood and has been quantified (Lugo, Miao, Rieke, & Lin, 2012). Lugo et al, has 
determined that if a QD is within a distance r from an ion channel, the ion channel can open and induce 
an action potential, as seen in Figure 10.  
 
 
Figure 10: The effect of the electric dipole moment of a QD can interact with an ion channel in order to stimulate an action 
potential in neurons, when the QD is within distance r of that channel. Adapted from (Lugo, Miao, Rieke, & Lin, 2012) 
 
 18 
  
Moreover, r=20nm when the medium between ion channel and the surface of the QD shell is 
pure water. The value of r decreases in biological environments, or when QDs are coated with polymers 
or proteins (Lugo, Miao, Rieke, & Lin, 2012). Now, scientists are exploring the possibility of using QDs to 
elicit specific signals in neurons. This can be used to better understand neuronal plasticity and network 
dynamics (Cossart, Ikegaya, & Yuste, 2005). 
Zinc Oxide nanoparticles have been shown to modify the profile and characteristics of action 
potentials (Jingxia, Lanju, Tao, Guogang, & Zhuo, 2008). At UNG, QDs used in culture cause unexpected 
effects with action potentials. The temporary voltage changes appear to trigger unexpected patterns of 
activity in hippocampal neuron cultures. Instead of orderly and sequential action potentials, all of the 
neurons appear to be depolarizing simultaneously and periodically. This makes experimental use of QDs 
as passive imaging agents for hippocampal neurons nearly impossible, as the QDs significantly change 
the functioning of the neural network. However, this effect has the potential to be used by scientists to 
intentionally stimulate action potentials, if more research is dedicated to understanding the mechanism 
of interaction of QDs and hippocampal neurons. 
 
2.4 Quantum Dot-Neuron Interaction with Calcium Imaging 
As discussed in Section 2.2.3, calcium is a good indicator of action potentials in neurons and the 
dye Oregon Green BAPTA (OGB) can be used to visualize the change in calcium concentration across the 
cell membrane. When calcium ions rush into the cell during an action potential, the OGB binds to the 
calcium and undergoes a conformational change. With a higher concentration of calcium, the dye 
fluoresces brighter, producing a higher intensity signal. OGB has an emission spectrum centered on the 
cyan color band at 488nm, with a peak excitation wavelength of 496nm and peak emission wavelength 
of 524nm (Long-Wavelength Calcium Indicators, 2005). 
 
2.4.1 Calcium Imaging Data 
Initially, calcium dyes are membrane-permeable, until they diffuse into cells, where the dye 
undergoes a conformational change to become membrane-impermeable. The molarity of the dye also 
changes as it is cleaved, so an excess of dye is able to accumulate inside the cell. After the unabsorbed 
dye is washed away from the culture, calcium imaging is performed using fluorescence microscopy.  
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There are, however, some inherent flaws with calcium imaging, as florescent intensity is 
dependent on many factors aside from the concentration of calcium in a cell. The concentration of dye 
loaded into cells can be highly variable between experiments and even between cells in the same 
culture. Additionally, intensity is influenced by the effective thickness of the neuron, as thicker neurons 
with more volume will have a greater concentration of calcium ions and accumulated dye relative to 
smaller neurons (Alberts, 2008). 
The approach to calcium imaging is relatively straightforward, as seen in Figure 11.  
 
 
Figure 11: Calcium imaging method; (A) Differential Interference Contrast (DIC) image with Region of Interests (ROIs) over 
hippocampal neurons, (B) Fluorescent calcium imaging, measuring the intensity of light in the ROIs, with OGB dye seen 
fluorescing in green. 
 
Regions of Interest (ROIs) are designated by colored circles in Figure 11A and represent the cell 
bodies of neurons. In a timelapse image, one frame of which is shown in Figure 11B, ROIs measure 
fluctuations in the intenisty of light from OGB over time, generated by a change in calcium 
concentration. Calcium concentrations are monotonic with action potentials, as discussed in Section 
2.2.3. A graph of the intensity of light versus time is shown in Figure 12. 
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Figure 12: Plotted Regions of Interest; these indicate large fluctuations in calcium concentrations (red region) until the 
sodium channel blocker, TTX, is introduced and stops calcium flow due to action potentials (blue region)  
 
The red highlighted region of Figure 12 indicates high levels of calcium signaling, a result of the 
presence of QDs in the culture. When TTX is introduced to the cells, sodium ion channels are blocked, 
ceasing action potentials and overall calcium activity. The introduction of test solutions containing drugs 
like TTX or QDs into cultures during live calcium imaging is a robust method to study the effects on 
networks of neurons. 
 
2.4.2 Current Microscope Setup at UNG 
The University of Nova Gorica at Vipava uses an Olympus IX81 Inverted Microscope and a 40x 
0.9 Numerical Aperture air-immersion objective lens for calcium imaging of cultures of neurons, such as 
those seen in Figure 11. Although the microscope contains complex software and optics, the physical 
setup is comprised of only a few simple subsystems. The subsystems that the device interacts with are in 
the immediate vicinity of the cell culture and are shown in Figure 13. The microscope components of 
interest include the base plate, the thermal control ring, the slide chamber, the microscope arm, and the 
perfusion system. 
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Figure 13: Olympus microscope calcium imaging setup; (A) base plate, (B) thermal control ring, (C) slide chamber, (D) 
microscope arm, (E) perfusion inflow, (F) perfusion outflow. 
 
The first piece of the calcium imaging setup is the base plate. The base plate is an 
interchangeable part that can be switched out to allow imaging with alternative base plates. In the case 
of calcium imaging, the base plate holds the thermal control ring. The plate is made of a nonmagnetic, 
painted aluminum alloy and may be snapped into and out of the microscope, as seen in Figure 14. While 
inserted into the microscope, the base plate may be translated in the horizontal plane by computer 
control. 
 
 
Figure 14: Parts of the base plate of the Olympus Microscope; (A) the void in the microscope that fits the base plate, with the 
objective lenses just below, (B) a computer model of the base plate, showing the thin ridges that the thermal control ring sits 
on 
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The base of the thermal control ring is a circular piece of nonmagnetic, painted aluminum that 
easily snaps into the base plate. The ring includes two-temperature control plug-ins and four pieces of 
steel on its surface. To achieve temperature control, cords must be plugged into both temperature 
control ports. In the current experimental setup, a magnet is attached to one of the steel plates and is 
used to hold the perfusion inflow in place relative to the slide. The thermal control ring is seen in Figure 
15. 
 
 
Figure 15: Computer model of the thermal control ring, with temperature control plug-ins on the left and right sides. 
 
The slide chamber consists of two donut-shaped rings that fit together with a friction-press fit. 
The slide, which has a cell-coated surface during imaging, is held between them. When the slide is 
inserted into the slide chamber, the composite system forms a dish, capable of holding liquid without 
leaking, as seen in Figure 16.  
 
 
Figure 16: The perfusion chamber, which holds a circular glass slide; (A) computer model of the chamber, (B) two pieces, with 
the red rubber seal that ensures a watertight press fit. 
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The microscope arm, as seen in Figure 17 holds the lighting and imaging apparatus for DIC 
imaging. The arm is capable of pivoting back to allow easier access to the base plate or slide, but must 
be in the fully forward position for imaging. The path between the slide and the bottom of the 
microscope arm must be unobstructed to allow for DIC imaging. 
 
 
Figure 17: The microscope arm; (A) in the fully forward position, (B) in the fully back position. 
 
Most in vitro calcium imaging is based on the use of a perfusion system, which streams a 
solution across the surface of neurons in a culture mounted to a microscope. The perfusion system at 
UNG, seen in Figure 18, involves a combination of parts, including the solution reservoir that holds and 
dispenses fresh Ringer’s solution to maintain cell health during imaging, as well as magnetic connections 
to adjust the positions of perfusion inflow and outflow tubing. 
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Figure 18: The perfusion system at UNG; (A) control solution reservoir at minimum height above the culture, dictating the 
speed of perfusion, (B) inflow tube, position affecting cell shearing, (C) the outflow tube, dictating the volume of solution in 
the slide chamber. 
 
Ringer’s solution is comprised of a combination of chemicals that together imitate the natural 
extracellular environment of the neuron. This solution can be administered by a perfusion system, which 
introduces fresh nutrients to the culture. Additionally, perfusion systems can administer drug 
treatments or nanoparticles to the culture. 
Numerous companies offer perfusion setups that can be adjusted for different microscopes. For 
example, Warner’s Instruments offers a setup that deliver stimuli to cells and are specialized to work 
with patch clamp technology. The current perfusion system at UNG is made from a medley of parts from 
different manufacturers that are not necessarily intended to fit together. However, this handmade 
system has the benefit of low cost. 
Around the entire microscope is placed a large cardboard box. This box helps to block ambient 
light from entering into the system during imaging. However, it also prevents users from accessing or 
seeing the slide during testing. This can prevent the experimenter from becoming aware of issues 
related to the perfusion system, such as flooding. 
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Figure 19: The cardboard box light shield; it completely blocks users from seeing or accessing the sample during imaging, but 
also blocks a large amount of ambient light from reaching the slide. 
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3 Project Strategy  
This chapter describes the steps taken to determine the appropriate approach to successful 
completion of this project.  
 
3.1 Client Statement  
The initial client statement challenged the team to design an experimental platform to 
investigate the interaction between Quantum Dots (QDs) and hippocampal neurons, as well as to 
characterize the role that QDs played in altering neuronal activity. Based on an initial proposal provided 
to the team by Dr. Pinato at the outset of the project1 the following client statement was determined:  
 
“Design a platform that allows for the determination of the relationship between quantum dots 
and observed voltage oscillations in hippocampal cells.” 
 
The Centre for Biomedical Sciences and Engineering was a new campus, located in the recently 
renovated Palace Lanthieri in the town of Vipava, Slovenia. This relatively young laboratory offered 
many opportunities for improvements to the current equipment and procedures, especially for a team 
of four Biomedical Engineering undergraduates from Worcester Polytechnic Institute. 
 
3.1.1 Current Methodology  
The interaction between QDs and hippocampal cells was best visualized by means of detailed 
imaging with a research-grade microscope. Cultures of hippocampal cells were mounted on the 
microscope platform and immersed in a solution inside the slide chamber.  
The existing microscopy system used a perfusion system to deliver the Ringer’s solution to cells. 
The delivery system used gravity to drive the inflow of Ringer’s solution from the solution reservoir to 
the slide chamber. A length of rubber tubing held on the far side of the dish used a vaccum pump to 
remove fluid from over the slide. The flow of liquid into the slide was termed the “Perfusion Inflow” 
                                                          
1
 The original document is available in Appendix A: Original Statement of Client Needs 
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system, while the pumping of fluid out of the slide was termed the “Perfusion Outflow” system. These 
systems can be seen in Figure 20. 
 
Figure 20: The path followed by the perfusion system; the “perfusion inflow” system, traced in blue, delivered fluid to the 
culture dish, where the “perfusion outflow,” indicated in orange, removed fluid from the top of the slide, with the volume of 
solution in the slide chamber indicated in green. 
 
The solution reservoir was filled with Ringer’s solution and mounted at a certain height above 
the slide.  A narrow tube with a valve connected the reservoir to the edge of the slide. When the valve 
was opened, fluid dripped into the cells’ environment at a rate proportional to the height of the solution 
reservoir. The height of the reservoir could be adjusted by sliding it up or down on a retort stand. To 
prevent fluid overflow and damage to the microscope, fluid was continuously removed by suction 
through the perfusion outflow system 
To introduce the test solution, the experimenter first waited until the solution reservoir drained 
to a multiple of 10mL of volume. A preloaded micropipette containing a defined amount of the test 
solution was then added into the reservoir. The concentration of test solution in the micropipette was 
chosen to give a final desired concentration with the volume of liquid in the solution reservoir. As the 
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system continued to perfuse, the concentration of test solution in the slide chamber gradually increased 
to the desired level. 
To return the system to the control condition, with no test solution in the system, the 
experimenter first waited until the exact moment that the solution reservoir emptied. This ensured that 
all of the test solution was in the tubing and that none would form a solution with anything else poured 
into the reservoir. The reservoir was then filled with the control solution. As the fluid perfused through 
the system, the concentration of test solution in the slide chamber gradually decreased. There were 
three primary issues with this experimental setup. 
1. The rate at which the nanoparticles and test solutions were delivered to the cells was slow and 
unknown. 
When the experimenter introduced the test solution or QDs into the system, the test solution 
took time to diffuse through the reservoir. More time was required to move the test solution through 
the tubing into the slide chamber. This was not ideal, as there was a period of time between the 
introduction of the test solution and the time that cells were exposed to the desired concentration of 
the test solution. Over the course of the introduction, cells experienced all concentrations between zero 
and maximum, and it was impossible to tell at what time full exposure occurred.  
2. The continuous perfusion required a large amount of the test solution be used. 
The entire remaining volume of liquid in the reservoir was brought to the desired concentration 
for each test. This volume of the reservoir was always at least 10mL, however, the actual amount of fluid 
in the slide chamber was assumed by UNG researchers to be approximately 0.5mL.  
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Figure 21: Volume of fluid in the slide chamber. Less than one milliliter of fluid immerses the cells in the slide chamber at any 
time during the test, with the liquid outlined in red for emphasis. 
 
The large volume in the reservoir created a significant waste of test solutions. It required a much 
smaller volume of test solution to bring the slide chamber to the desired concentration than to bring the 
reservoir to desired concentration. 
3. The relative positions of the inflow and outflow tubes were highly variable. 
A small magnet was used to secure the end of the inflow tube in place. The cells likely 
experienced variable micro-currents, as the magnet was manually applied for each test. This may have 
altered the shear stresses experienced by cells and the rate of perfusion between tests. Additionally, the 
perfusion outflow system was secured by double-sided tape, which had to be replaced every few tests 
and was not reapplied in a predictable position.  
 
3.1.2 Revised Client Statement  
After using the existing experimental procedures, having conversations with researchers at 
UNG, performing literature reviews, and holding internal group discussions, the following revised client 
statement was generated:  
”Design a device which allows for the rapid and controlled introduction of an experimental 
solution onto the slide of a microscope. This device must minimize the amount of the test solution or 
quantum dots used.” 
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The final client statement was a mutual understanding of the scope of the problem between the 
engineering team, researchers at UNG, and WPI advisors, as well as the problem’s solution as it 
prioritized the needs for waste reduction and increased efficiency of the system.  
 
3.2 Objectives, Constraints and Functions  
Objectives, constraints, and functions define the scope of the project. These are the benchmarks 
for either success or failure. Objectives are chosen as higher-level goals for project completion, serving 
as the basis for creating a design and evaluating its performance.  Constraints describe the limitations of 
the device. Functions define the capabilities the device needs to possess. The following section defines 
these parameters, as chosen by the team. 
 
3.2.1 Objectives 
From the previous client statement and discussions with UNG researchers, the following five 
objectives were chosen as the most relevant to the success of the project. The objectives of low cost, 
operator friendliness, consistency, multifunctionality and streamlined condition delivery were each 
broken down into more detailed descriptions of the objectives.  
 
Table 1: Top level project objectives; these objectives define the benchmark, which must be met for the project 
to be considered a success. 
Low Cost The total cost of all components should not exceed the budget for the project. 
This does not exclude use of materials which have already been purchased by 
UNG researchers. 
Operator Friendliness The device should be easy to set up, use, and break down. 
Consistency Multiple uses of the device should yield comparable and empirically valid 
results. 
Multifunctionality Device should be capable of being used with multiple types of imaging and 
additional microscope-based techniques. 
Streamlined 
Condition Delivery 
Device should increase the efficiency of delivery of the experimental test 
condition, drug, QD, or other test solution. 
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In order to determine the importance of these objectives, we used a Pairwise Comparison Chart2 
(PCC). PCCs are tools used to rank objectives in terms of their importance to the project. 
 
Table 2: Pairwise Comparison Chart; Determines ranked objectives. The totals are a relative score of importance, 
with higher numbers denoting a greater importance. 
 
 
The comparison revealed to the team that the device should be, from most to least important, 
consistent, streamlined for condition delivery, low cost, operator friendly, and multifunctional. Each of 
the objectives is clarified below. 
1) Consistency 
UNG was in need of a consistent, repeatable procedure. This device would continue to be a part 
of several experiments; therefore the need for consistency is vital to the results. The system must be 
reproducible in delivery, flow, and flushing methods. These components must be consistent from test to 
test so all of the data obtained is both comparable and valid.   
2) Streamlined Condition Delivery 
Since a variety of expensive drugs and other test solutions or nanoparticles would be sent 
through this system, the device needed to use a minimum amount of test solution. The device should 
optimize the delivery of the test solution to ensure minimal waste and rapid administration to the cells.  
3) Low Cost 
This device must be able to be manufactured using current materials and processes found in a 
basic laboratory setting, while requiring minimal out-of-pocket expenses. The design of this device must 
                                                          
2
 In each cell, the row objective is compared to the column objective. If the row objective is more significant, a one 
goes in the cell. If the column objective is more important, a zero goes in the cell. ½ is awarded for objectives of 
equal importance. The sums of the rows provide a relative measure of importance (Dym & Little, 2009). 
Low Cost
Operator 
Friendly
Consistent Multifunctional
Streamline 
condition 
delivery
Totals
Low Cost 1 0 1 0 2
Operator Friendliness 0 0 1 0 1
Consistency 1 1 1 1 4
Multifunctionality 0 0 0 0 0
Streamlined Condition Delivery 1 1 0 1 3
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also allow for more efficient use of material, particularly cell media and test solutions, to reduce the 
waste and need to frequently replenish supplies.  
4) Operator Friendliness 
This device must be as simple to use as possible, minimizing human error, therefore reducing 
the possibility of compromising data. 
5) Multifunctionality 
Being multifunctional is valuable, but not imperative, to the client. The primary concern of the 
client is to examine the functionality of QDs, with other experiments secondary.  
 
3.2.2 Constraints 
Constraints are the limiting factors of a design. The success of the design is heavily weighted on 
the constraints. Failure to understand and properly manage these, typically results in a failed design. 
Below is the original list of constraints for the device developed after the revised client statement. 
 Mechanical Interference - The height and volume of the system do not interfere in any way with 
the imaging process. 
 Self-Supporting - The device must be sturdy and capable of holding itself up with no other 
support systems or special precautions. 
 Minimal Dexterity - The device must not require any particular skill to operate. Any operator 
with the requisite microscopy skills should be able to operate the device and the introduction of 
the test solution and microscopy must not be mutually exclusive events. 
 Manageable Set-up/Breakdown - The device must not take more than 10 minutes to either 
setup or breakdown. 
 No Cell Shearing - The device must not create a flow that produces a shearing force strong 
enough to cause partial or full detachment of neurons from the glass slide. 
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 No Damage to the Objective Lens - The device must not come in close contact with the delicate 
and expensive objective lens of the microscope.  
 
3.2.3 Functions 
Functions are the necessary tasks the device must complete in order to be a successful design. 
Our client statement performed four main design functions. 
First, the system was able to keep the cells submerged in solution, as continuous immersion was 
vital to continued cell health. If the cells were at any time not immersed, their behavior would have 
changed, invalidating experimental results. Discussions with the UNG researchers and initial 
observations revealed that distressed cells, those in undesired environmental conditions, tended to 
exhibit baseline drift of calcium levels. This masked potential electrical activity that may have occurred; 
therefore it was avoided. 
Secondly, the system maintained consistent placement of the inflow of fluid from the perfusion 
system and the outflow of fluid from the slide. A combination of magnets and tape was used to attach 
the perfusion inflow and outflow systems, resulting in testing inconsistencies. Varying patterns of flow 
over the slide caused irregular microcurrents and unpredictable cellular exposure in different regions of 
the slide chamber. While consistent placement of inflow and outflow tubes did not eliminate this issue, 
it likely helped to alleviate inconsistencies. 
Another necessary function of this device was the ability to restore the initial control condition. 
The difference between the baseline and experimental concentrations of the test solution needed to be 
consistent between tests. After the introduction of the test solution or nanoparticles, the system 
needed to incorporate a way to lower the concentration back to control solution concentration. This 
involved flushing out the system to completely replace the test solution with the control solution.  
Finally, the system had to be capable of blocking ambient light sources from the cell culture. 
Fluorescence microscopy is a delicate imaging process and any external light interference reduced the 
noise in images, which reduced data quality. 
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3.3 Project Approach  
Objectives, constraints, and functions serve to guide the direction of this project. To ensure that 
all project requirements were met, a series of steps were followed. First, a Work-Breakdown Structure 
(see Appendix B: Work Breakdown Structure) was drafted. This tool orders and characterizes the various 
steps needed to complete the project. It was continuously updated as new tasks were identified. 
Additionally, a Gantt Chart (available in Appendix C: Gantt Chart) was created to allow for planning and 
tracking of the project status. 
Following a brainstorming session, a series of design alternatives were generated. The feasibility 
and relative usefulness of these designs were evaluated using a number of tools, including a function-
means table and a design evaluation matrix.  
A series of prototypes were developed and tested. The information gained from this testing 
informed the design and manufacture of a final device. Protocols were developed to verify the 
conformity to specifications of this design, validate the design, and generate useful data for evaluation 
by UNG researchers. 
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4 Design Alternatives and Evaluations 
A vital step in the design process is the generation of design alternatives. Creating multiple 
options to work with allows for the best possible design to be chosen and minimizes the odds of a failed 
project. To generate and assess designs during this process, tools such as a functions means tree and a 
design evaluation matrix were used. Each necessary component of the new device was evaluated to 
determine which of the objectives would be satisfied, and whether or not they fell within the bounds of 
the constraints. Through these methods, the feasibility of each combination of potential systems was 
considered. 
 
Table 3: Morphological Chart of the functions and means of the device 
Functions Means 
Keep cells 
submerged 
open-to-air 
perfusion 
open-to-air 
reservoir 
removable 
closed 
perfusion 
  
Input challenge 
gravity based 
system 
syringe into 
pump 
cyclic pumping micropipette 
Remove challenge 
vacuum and air 
pump 
peristaltic 
pump 
closed gravity 
system 
  
Mount 
inputs/outputs 
polyurethane 
platform 
carbon fiber 
platform 
plastic ring 
with O-ring 
  
Secure mount Magnets 
adhesive 
polymers 
tape   
Clean Equipment UV light bulbs 
Isopropyl 
alcohol 
Ethanol 
 
 
Four alternatives that utilized a variety of the means in Table 3 were considered. With further 
evaluation, the team considered various designs that fulfilled the objectives. By brainstorming a diverse 
list of alternatives, the team highlighted design criteria and specifications that might otherwise have 
been overlooked. 
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4.1 Design Specifications 
Design specifications are critical in the design process, as they provide explicit information about 
the requirements of the system or device. The specifications below were decided upon based on the 
need for adherence to the objectives, functions, and constraints. Validation criteria for each of the 
specifications are described in Section 5.1.8.  
Table 4: Specifications of the Design; the leftmost column describes the motivating rationale for the decision, while the 
central column describes the exact wording. The rightmost column explains why that wording was chosen. 
Needs Specification Rationale for Specification 
Cells must be kept 
submerged in solution 
At no point during the process of cell 
installation or testing shall the cell-
carrying surface of the slide be 
exposed to air 
Cells will become distressed or 
die if exposed to air for any 
significant period of time 
 Device must alert the user before 
running out of the control solution 
The perfusion in system must be 
a continuous flow 
Cells must be able to be 
exposed to precise 
concentrations of the 
experimental condition 
The control concentration of test 
solution must be +/- 1 mM the 
expected value initially 
The ±1 mM level was agreed 
upon by the team and Dr. Pinato 
 The experimental concentration of 
test solution must be +/- 1 mM the 
expected value 
The ±1 mM level was agreed 
upon by the team and Dr. Pinato 
 
The final concentration of test solution 
must be +/- 1 mM the expected value 
The ±1 mM level was agreed 
upon by the team and Dr. Pinato 
Size and shape cannot 
provide any limitations 
No part of the device must 
mechanically interfere with any part of 
the operation of the microscope 
The microscope has multiple 
moving parts, including the stage 
and the arm. An incorrectly 
shaped device would inhibit 
microscope functionality by 
reducing its range of motion 
No manual dexterity 
No part of device setup, operation, or 
breakdown must depend on an 
unusual degree of manual dexterity 
Injection of the test solution is a 
challenging task in the current 
microscopy setup, requiring 
delicate and skilled movements 
to inject small volumes without 
shearing cells. 
No interference with 
fluorescent imaging 
No device component shall intrude 
upon the space between the slide and 
the objective lens 
Certain paths between the slide 
and lenses of the microscope 
must be kept clear of 
obstruction. In particular, no 
part of the design should intrude 
into the area either directly 
above or directly below the slide  
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Self-supporting device 
The device shall be stable enough such 
that falling over and detachment are 
not concerns of experimenters 
It may become necessary to 
directly attach a bulky 
micropipette or other equipment 
to the device. Nothing unstable 
will be acceptable 
Quick setup and removal 
The device shall take an experimenter 
less than ten minutes to fully set up 
There is approximately thirty 
minutes between dye loading 
and calcium imaging. In this 
time, the experimenter must 
also follow the procedure 
outlined in Appendix D: Standard 
Operating Procedure for Staining 
Cells Prior to Imaging to setup 
the microscope. If setup took 
more than 10 minutes, the 
overall process would require 
more than 30 minutes. 
 The device shall take an experimenter 
less than ten minutes to fully break 
down 
It was agreed that the 
breakdown should take no 
longer than the setup. 
Microscopy and 
introduction of test 
solution are not mutually 
exclusive 
The introduction of the test solution 
and microscopy must not be mutually 
exclusive events 
The time period immediately 
after the introduction of the test 
solution contains valuable data, 
as it will show the immediate 
cellular response to the new 
environment. If imaging was 
interrupted, this data would be 
lost 
No cell shearing The speed and type of flow caused by 
the device must not damage or disturb 
the network of hippocampal neurons 
It will be impossible to collect 
data from neurons if they are 
not adhered to the slide surface 
Constant inflow and 
outflow positions  
 Any inflows and outflows to the cell 
culture must remain at constant 
positions relative to one another and 
to the slide from test to test 
Consistent placement of the 
inflow and outflow ensures a 
consistent volume of fluid in the 
slide chamber, which is ensures 
accurate final concentrations of 
test solutions 
Temperature control The temperature of the cells must be 
kept within 1 degree Celsius of any 
desired temperature between room 
temperature and 40 degrees Celsius 
Two thermal control plug-ins 
exist on either side of the 
thermal control ring. Access to 
them must be unimpeded. 
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4.2 Design Alternatives 
The team developed four possible designs which they felt were capable of fulfilling all of the 
above specifications.  
 
4.2.1 Design 1: Open System with Selectable Perfusion 
The initial design is based on a reasonably simple modification of the current design. Rather 
than a continuous perfusion, the solution inflow may be turned on by electronic or manual control. The 
perfusion outflow pump may also be turned on or off in the same manner. When both inflow and 
outflow are turned on, a known volume of solution will be left coating the sample. 
When the test solution is ready to be introduced, both perfusion inflow and perfusion outflow 
could be switched off. The volume of the static solution remaining in the slide chamber would remain 
consistent, because the placement of the perfusion outflow would remain at a constant height relative 
to the slide. As this volume of solution is constant for every test, the precise final concentration of test 
solution or nanoparticles to be added could be calculated with reproducible accuracy. To return the cells 
to the initial control condition, perfusion outflow and inflow may both be turned back on, clearing test 
solution from the sample. 
 
 
Figure 22: Computer model of the open perfusion system; the clear micropipette tip would administer control solution into 
the slide chamber. At the desired time, this control solution could be supplemented with the test solution by the purple 
micropipette tip. Waste would be removed through the red micropipette tip. 
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As with all design alternatives, there were several factors to consider when weighing the 
benefits and concerns of each idea. For this design, DIC imaging, which relies on an unobstructed view of 
the top of the sample, as well as the bottom, would still be able to occur.  As described in Section 2.4.2, 
bright field illumination is necessary for DIC microscopy. Since this design would be similar to the 
existing setup, some components could be kept, such as the perfusion outflow pump and the gravity-fed 
perfusion inflow system, in order to simplify installation and reduce cost.  There was also the potential 
for variability in the volume of liquid in the slide chamber, which might have caused variation in the 
concentration of the test solution. This variability might be due to issues related to suction, placement 
of the perfusion outflow tube, and evaporation of solution. 
 
4.2.2 Design 2: Closed System with Selectable Perfusion 
 
Figure 23: Computer model of the closed perfusion system; the clear micropipette tip would input control solution into the 
central, completely enclosed blue slide area. At the desired time, this control solution could be supplemented with the test 
solution by the purple micropipette tip. Waste would be removed through the red micropipette. 
 
During setup of this closed system, a watertight seal would be made between the bottom of a 
small enclosure and the slide chamber. The only openings in this small chamber would be the perfusion 
inflow to deliver the control solution, the micropipette tip to deliver the test solution or QDs, and a 
small opening for perfusion outflow. 
As opposed to a continuous perfusion system, the fluid inflow system could be turned on by 
electronic or manual control, as in the open system. The perfusion outflow system would be entirely 
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passive. During perfusion, the control solution would actively pump through the perfusion inflow 
system. This inflow would fill the enclosed slide chamber to completely cover the cells, forcing excess 
solution through the outflow. To introduce the test solution, the inflow pump would be switched off, to 
leave static solution in the slide chamber. A test solution would then be pumped into the chamber by a 
secondary micropipette, forcing out the control solution and flooding the enclosed area. To remove the 
test solution, the inflow perfusion system could be turned on to flood the system with control solution 
and force all test solution into the waste beaker. 
This would be a fairly simple design, in that the perfusion outflow would be passive rather than 
requiring some type of suction or peristaltic pump. Another benefit to this design would be that the 
volume of liquid to which the cells are exposed is known, as it would be equal to the volume inside the 
enclosed slide chamber. The difficulty with this system could come with forming a consistent seal 
between the enclosure and slide chamber. Without an accurate seal on the device the volume, as well 
as the positioning of the perfusion in and perfusion out pipettes would be affected, and most likely 
inconsistent. 
 
4.2.3 Design 3: Closed Loop Perfusion System 
In this closed loop design, there would be no waste container. Instead, all material could be 
circulated through the system in a loop, with a beaker serving as a fluid reservoir. Only a small volume of 
liquid would be maintained in the slide chamber itself at any given time.  
Initially, only the control solution would be contained throughout the system. The level of fluid 
in the large beaker would be kept low. When desired, a secondary syringe or micropipette could inject 
an appropriate amount of high concentration test solution into the beaker, which would be distributed 
by means of diffusion and convection. 
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Figure 24: Computer model of the closed loop system; a cyclical, pump-based perfusion design would continuously deliver 
liquid to the slide chamber by pump and recycle back to a beaker with secondary syringes allowing for modification of 
concentration. 
 
To return the system to a negligible level of the test solution, a large amount of the control 
solution, likely half a liter or more, would need to be injected into the system by a large syringe or other 
pump. This should not entirely remove the test solution from the system, but  dilute the test solution to 
an arbitrarily low concentration. 
One of the design objectives is to reduce the amount of test solution or QDs used in a test. This 
design would not only create little to no waste of the test solution or QDs, but it also would significantly 
reduce the amount of the control solution used, as all fluids repeatedly circulate through the system.  As 
a closed loop system, this design would require a more complex setup and breakdown process. Two 
pumps would be needed, increasing the complexity and chances of failure of the device. Due to the fact 
that the syringes would inject solution into the reservoir rather than onto the slide itself, there would be 
a delayed delivery of the appropriate concentration of test solution to the cells, and it would become 
more difficult to return the system to the initial concentration of test solution. Depending on the desired 
concentrations and volumes required throughout the tests, it might be impossible to dilute the test 
solution to negligible levels. In addition, cell byproducts might potentially alter the effect on the 
solutions over the course of experimentation. 
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4.2.4 Design 4: Static Beaker System 
 
Figure 25: Computer model of the static beaker system; rather than using flow, a small amount of control solution would be 
above the slide, after which control or test solutions could be introduced, while mixed solutions could be removed. 
 
The fourth and final design is a static system with no perfusion at all. Initially, the cells would be 
bathed in a small amount of the control solution. During an experiment, an appropriate amount of 
highly concentrated test solution could be injected into the slide by the yellow syringe (seen in Figure 
25). Through diffusion, the small amount of control solution already in the beaker would mix with the 
newly injected test solution, to produce the desired concentration. To return the concentration of the 
test solution to a negligible level, large amounts of control solution would be injected through the blue 
syringe, while outflow is allowed through the red syringe. This would eventually lower the concentration 
of the test solution to whatever arbitrarily low level is desired by the user.  
While this design idea could appear to be the simplest to implement, as it likely requires little 
tubing or hydraulics, there could be several downsides to the design. Maintaining the desired 
concentrations of solution may prove difficult, given that there would be no outflow. The increased 
water pressure above the cells could modify their physiological response in unexpected ways. Most 
importantly, a leak or other mechanical failure would douse the system with a large volume of salt 
solution, a catastrophic result. Such an incident could damage electronics and leave particulate coatings 
on optical components, reducing the utility of the microscope for future experiments. 
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4.3 Design Evaluation Matrix 
Based on the team’s chosen objectives, the following Design Evaluation Matrix3 was 
constructed, which compares the four possible alternative designs. Each of the five objectives was given 
a weight between one and ten, proportional to its importance to the success of the design. 
1. Consistency (1.0) – The Pairwise Comparison Chart in Section 3.2.1 revealed consistency 
to be the most important of the five objectives. It was therefore given the maximum allowable value of 
one. 
2. Streamline Condition Delivery (0.8) – Discussion with the client, along with the high cost 
of QDs, made delivering efficient quantities of test solutions or nanoparticles highly desirable.  
3. Low Cost (0.5) – Any design that was too expensive for the team to construct was 
useless to researchers at UNG. However,  only one such device would ever need to be made. The design 
of the device would be specific to this microscope and laboratory. Unless the laboratory either obtained 
a second Olympus microscope or broke the device, there would be no need for construction of a 
second. 
4. Operator Friendly (0.3) – While it would be helpful and convenient for the design to be 
easy-to-use, functionality trumps other considerations. A device that works well and allows for the 
collection of good data would be more valuable than one that is easier to use. A score as high as 0.3 was 
awarded based on the knowledge that complicated instructions for use could increase the chance of 
human error, and make the device less useful. 
5. Multifunctional (0.2) – While it would be convenient for the laboratory to have a general 
device, usable in other experiments, the task given to the team was to investigate the relationship 
between QDs and neurons. It would be acceptable for the design to only be applicable to that particular 
case. 
It is important to note that this order of importance matches the order of importance given by 
the Pairwise Comparison Chart in Section 3.2.1. Given below is rationale for the scores awarded to each 
of the designs. 
                                                          
3 A Design Evaluation Matrix is a method to compare the feasibility of a variety of designs. Each of the alternative 
designs is given a relative weight, between zero and one, which is proportional to its importance to the success of 
the design. For each of these categories, the design alternative is given a score between one and ten, proportional 
to how well it would fulfill the objective. The products of these scores and weights are added together, generating 
a total score for each of the design alternatives. These scores represent a measure of relative ability for the design 
to fulfill the objectives of the project (Dym & Little, 2009). 
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4.3.1 Open Perfusion System 
1. Low Cost (8.5) – The open perfusion system required no additional pumps and would 
likely be able to reuse many components of the existing perfusion system. 
2. Operator-Friendly (6.5) – It would be easy to use this design beyond the current 
requirements of the existing perfusion system. However, that system would not be optimal, as it proves 
to potentially have leaks or run out of control solution. 
3. Consistency (6.0) – The main source of inconsistency in the open perfusion system 
would be the potentially variable volume. As the volume of fluid over the slide would be defined only by 
the height of the outflow pump instead of by an enclosed chamber, a chance for inconsistency existed. 
4. Multifunctional (10) – The open perfusion system required the fewest materials and left 
the maximum possible amount of open space above and below the slide. This would make it likely to 
work with a variety of imaging techniques. 
5. Streamlined Condition Delivery (9.0) – A completely exposed droplet of liquid over the 
slide chamber would have made it easy to inject test solution into the system with a micropipette, 
requiring no additional techniques or equipment. 
 
4.3.2 Closed Perfusion System 
1. Low Cost (7.0) – The closed perfusion system would have required some an enclosed 
microfluidic chamber to be effective. As the Centre for Biomedical Sciences and Engineering had no 
equipment capable of producing such a chamber, it would likely have been required that construction 
be completed out-of-house at some cost. However, most components of the existing system would have 
been salvageable. 
2. Operator-Friendly (6.0) – The chief problem of the open perfusion system would have 
been eliminated by the closed design, as the system volume would be strictly defined. 
3. Consistency (8.0) – The chief problem of the open perfusion system would have been 
eliminated by the closed design, as the system volume would be strictly defined. 
4. Multifunctional (2.5) – The enclosed chamber would have blocked the light path up to 
the microscope arm, and have made many types of imaging, including DIC, impossible. 
5. Streamlined Condition Delivery (8.5) – A very small and precise amount of test solution 
or QDs would have been required for each test, minimizing waste. However, the volume used would 
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have needed to be greater than the volume of the chamber to ensure that the control solution would 
have been completely flushed out of the system. 
4.3.3 Closed Loop Perfusion System 
1. Low Cost (4.0) – The closed loop would have required at least two flux pumps, neither of 
which was owned by the Centre for Biological Research and Engineering. A vacuum pump was used in 
their previous setup. This represented a significant cost increase. 
2. Operator-Friendly (4.5) – Management of two pumps and tracking of the total volume of 
a dynamic system would have been complicated tasks, which would have required significant skill and 
attention to manage. 
3. Consistency (5.5) – The unclear time delay between the injection of the test solution and 
the time of delivery to cells would have introduced variance into the system. 
4. Multifunctional (10) – No unnecessary components would have been placed near the 
slide chamber; only inflow and outflow tubes would have been needed at that location.  This would have 
maximized the possibility for use of other imaging modalities or microscopy techniques. 
5. Streamlined Condition Delivery (2.5) – The unknown delay might have led to 
inconsistency, and might also have led to an unclear relationship between the test solution and neural 
response. 
 
4.3.4 Static Beaker System 
1. Low Cost (8.0) – The static beaker system would have required no tubing or pumps, 
making it potentially the least expensive of the four design alternatives. 
2. Operator-Friendly (4.5) – Balancing a large reservoir on top of a slide would have been a 
challenging task, and the production and use of such large quantities of solutions would have been 
inconvenient. 
3. Consistency (6.0) – The design would have been dependent on potentially slow diffusion 
of solutions throughout the reservoir, causing an unclear relationship between the administration of the 
test solution and neural response. 
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4. Multifunctional (3.0) – The large reservoir would have interfered with components of 
the microscope needed for other types of imaging, limiting the use of the design to solely fluorescence 
microscopy. 
5. Streamlined Condition Delivery (4.0) – The delivery of test solution to cells would have 
been entirely dependent upon slow diffusion through a large volume of fluid. 
 
4.3.5 Finalized Matrix 
Table 5 shows the finalized Design Evaluation Matrix, comparing the relative utility of the four 
alternatives. 
 
Table 5: Design Evaluation Matrix of the four design alternatives; the totals on the far right are relative scores of the 
suitability of the design to our needs. An open perfusion system appears to be the most suitable design alternative 
 
 
Based on these results, it was decided that the open perfusion system held the greatest 
potential for delivering successful experimental results. 
 
  
Objective Low Cost Operator Friendly Consistent Multifunctional Streamline Delivery Total
Weight 0.5 0.3 1 0.2 0.8
Open Perfusion 8 6.5 6 10 9 21.15
Closed Perfusion 7 6.5 8 2.5 8.5 20.75
Closed Loop 4 4.5 5.5 10 2.5 12.85
Static Beaker 8 4.5 6 3 4 15.15
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4.4 Prototypes 
The early phases of design and construction used readily available materials to test features of 
the open perfusion system and ensure that unexpected and overlooked characteristics of the design 
would not lead to engineering failure. 
 
4.4.1 Prototype One: Results & Modifications 
 
Figure 26: Components of the first prototype design; (A) dimensioned drawing of the disc which formed the basis of the first 
prototype design, with cutouts on the left and right to allow for access to the thermal control plug-ins, a teardrop-shaped 
groove at the 10:00 position that helps to stabilize the micropipette used to inject the test solution into the slide chamber, 
and two cuts at 90 degree angles from the orientation of the teardrop shape to allow access to the slide for the perfusion 
inflow and outflow systems, respectively, (B) computer model of the magnetic perfusion inflow holder in contact with two 
noted edges of the disk, (C) additional components to be glued to the main disk, (D) a guide component for holding the test 
solution micropipette, (E) a computer model of prototype one, showing the slot for the perfusion inflow system, the holder 
for the perfusion outflow pipette, and the test solution in guide system, and (F) the assembled disk of prototype one  
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The focus of the first prototype was the standardization of the locations of the perfusion inflow 
and outflow components of the design. To do this, a layer of 3mm black polyurethane (trade name 
hobbycolor4) was cut to the measurements specified in Figure 26A, using a combination of hacksaw, 
wire cutter, sandpaper, and drill techniques.  
This part of the design was intended to be placed on top of the thermal control ring. Cutouts on 
the left and right sides of the device allowed access to the thermal control plug-ins and therefore, would 
allow temperature-controlled experiments. As the intent of this design was to test the placement of 
perfusion inflow, perfusion outflow, and test solution injection components, the decision was made to 
use the existing magnetic perfusion inflow system, but to replace the perfusion outflow system with a 
micropipette tip, connected by rubber tubing to the outflow pump. A groove was cut into the lower left 
of the disk, to allow the perfusion outflow tube access to the edge of the slide. On the top right of the 
disk, an angled wedge was cut out. This enabled the round, magnetic perfusion inflow holder to be slid 
from the outside to the inside of the thermal control ring until it made contact with both sides of the 
wedge, therefore maintaining a relatively consistent position from test to test. The magnetic holder and 
wedge-shaped cut can be seen in Figure 26B. 
Additionally, several other pieces of the same material were cut out using the same hand tools 
as the primary disk. The left-hand component seen in Figure 26C, glued to the top of the disk as seen in 
Figure 26E, was intended as a guide for injection by micropipette into the slide. Contacting the 
micropipette to both this groove and the adjacent notch (the test solution guide of Figure 26E and F) 
would ensure that test solution is injected from the same angle on each test. Four copies of the right-
hand component seen in Figure 26C, glued to the bottom of the disk, are designed to hold the device in 
place by hooking over the edges of the metal plates on the thermal control ring.  
Additionally, a triangular component seen in Figure 26D was cut out. This was designed to hold 
the outflow micropipette tip at an appropriate angle, such that the tip would barely make contact with 
the edge of the slide. Such an arrangement would keep the cells bathed in solution while minimizing the 
actual volume of solution in the slide chamber. 
A computer model and assembled version of prototype one can be seen in Figure 26E and F, 
respectively. The physical device only significantly differed from the computer model in the precision of 
the cuts. 
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However, initial testing quickly determined several issues with this design. First, the metal 
holder used to keep the thermal control ring in place caused an interference with the edge of the 
assembly, preventing the assembly from being flush against the top surface. 
 
 
Figure 27: The interference of prototype one with the metal holder; prototype sits just on top of the holder, preventing a 
flush and consistent placement. 
 
Consistent placement of the device is important to maintain the volume in the slide chamber 
and eventually to delivering precise concentrations of test solutions. 
Second, the hobbycolor material proved to be too malleable even for the purposes of short-
term, prototype use. The material acts more like a piece of semi-rigid foam than a piece of hard plastic, 
and was deformed during early use.  
 
4.4.2 Prototype Two: Results & Modifications 
To alleviate the issues of prototype one, two major changes were made. First, the material for 
the disk was changed to a 5mm sheet of plexiglass. The team’s hope was that the stronger, more rigid 
surface would improve the accuracy of the cuts and produce a more durable component that could be 
extensively tested.  
 Second, a large cut was made in the side of the base, to avoid interference with the metal 
holder (Figure 28). Due to significantly easier manufacturing, all components other than the main plate 
were still comprised of hobbycolor. 
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Figure 28: Computer model and real model of the revised prototype; note the flat surface on the left side of these images, 
intended to avoid interference with microscope components 
 
The other major improvement in prototype two was the addition of a light shield, as seen in 
Figure 29. This component is designed to block all ambient light from reaching the sample. This part was 
designed as two hollow cylinders comprised of a UV resistant material, connected by a ring of the same 
material. The lower cylinder would have a diameter equal to the outer diameter of the entire prototype, 
and the upper cylinder would have a diameter exactly equal to the diameter of the microscope arm 
above. Slits in the side of this component would allow for the perfusion inflow and outflow systems, as 
well as allow for the introduction of the micropipette, when needed. 
 
 
Figure 29: The light shield of prototype two; (A) computer model of the prototype two light shield, with various holes are cut 
into the sides to allow for the perfusion systems and the injection of the test solution, (B) the disk of prototype two and light 
shield, and (C) the assembled prototype two 
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The light shield component seen in Figure 29B and C was manufactured from metal repurposed 
from aluminum cans. This material was chosen for its ease of processing, UV blocking capabilities, and 
availability. Connections between the pieces of aluminum were made with electrical tape. 
Two major issues were revealed by this test. These can be seen in Figure 30. First, the tight fit 
between the top of the light shield and the microscope arm caused mechanical interference when trying 
to image any part of the slide besides the exact center. This is an undesirable outcome, as it severely 
limits the regions of the cell culture that can be imaged. 
Second, the angle of the intended injection from the micropipette interfered with another 
microscope component, the camera. 
 
 
Figure 30: Issues with prototype two; (A) there is not enough space between the microscope arm above and the light shield 
below for the microscope to image every section of the slide without mechanically interfering with the light shield, (B) the 
microscope camera exists at the same angle relative to the slide as the opening for test solution injection, making injection 
by micropipette difficult.  
 
While overall successful, there were clear changes to be made for future iterations of the design 
to ensure that there would be no further mechanical interferences. 
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4.4.3 Prototype Three 
The third design iteration, seen in Figure 31, addressed the changes deemed necessary from 
prototype two. The micropipette guide was moved by 45 degrees to allow user access from an angle 
without mechanical interference with the camera. 
 
 
Figure 31: Prototype three, featuring a 45 degree shift in pipette access point; note the taped on micropipette, which serves 
as the perfusion out system 
 
More significantly, the top section of the light shield was modified from that of prototype two, 
as seen in Figure 32. The diameter of the top section was increased to avoid any possible interference 
with the microscope arm. To minimize the entrance of light through this new opening, the height of the 
light shield was maximized, as to not interfere with the hinged movement of the microscope arm.  
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Figure 32: A comparison of the prototype two and three light shields; (A) the shorter light shield of prototype two, and (B) 
the taller light shield of prototype three 
 
This prototype appeared to work well for the purposes of blocking light from entering the 
sample. The increased height meant that the microscope arm extended below the top edge of the 
shield, leaving few direct paths by which light from the outside environment could reach the slide. 
Second, the repositioned opening for injection of the test solution significantly increased the 
ease of use for the experimenter, reducing the required degree of manual dexterity. 
 
4.4.4 The Low Fluid Alarm 
To satisfy the need for the cells to be constantly bathed in solution outlined in Section 0, it must 
be possible for some part of the device to alert the user before the control solution in the reservoir runs 
out. To accomplish this, a system known as the Low Fluid Alarm was created. 
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Figure 33: A simplified diagram of the Low Fluid Alarm system; a floating buoy inside the reservoir moves with the level of 
solution. As the level decreases a circuit is completed that turns on a light-emitting diode.  
 
The Low Fluid Alarm is based around a floating buoy, which will rise and fall with the level of 
solution left in the syringe. This buoy must have three properties; (1) have a density lower than that of 
water (1 g/cm3), (2) have enough mass to pull down on an electrical switch (a mass dependent on the 
exact construction of the switch), (3) fit into the fluid filled syringe with a minimum of friction against 
the walls. The tube has an inner diameter of 28mm, meaning that any object serving as the buoy must 
be no larger than this. Combined, these properties ensure that the buoy will move up and down 
smoothly with the level of the control solution in the reservoir. 
To accomplish this, a microcentrifuge tube was chosen, seen in Figure 34A. These are small, 
sealable plastic containers, typically used for the storage of a few microliters of solution during 
centrifuging. They are highly nonreactive, easily cleaned, have dependable properties over a wide range 
of conditions, and are naturally buoyant when closed. 
Small stones were added one by one to the inside of the tube, with the buoyancy of the tube 
tested in warm water after the addition of each stone. An equilibrium point was determined, at which 
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the tube held exactly as many stones as possible while still remaining buoyant, satisfying properties one 
and two. The filled tube can be seen in Figure 34B. 
 
 
Figure 34: Major components of the Low Fluid Alarm; (A) An empty microcentrifuge tube, (B) the microcentrifuge tube after 
the addition of stones to increase mass, (C) electrical components of the visual indicator system, (D) a detatchable 
component which fits over a flange of the solution reservoir, to allow for the installation and removal of the alarm, (E) the 
electrical switch of the device, in which can be seen the plastic fiber that either pushes up on or pulls down on the length of 
rigid wire, depending of fluid level in the reservoir, and (F) the contact of the electrical switch, comprised of a rigid wire and 
aluminum foil. 
 
The next design decision was the determination of an indicator. Both auditory and visual alarms 
were considered. A visual indicator was determined to be the preferable choice. First, the necessary 
components were already available to the team. Second, a bright visual indicator would always be 
immediately noticeable in the darkened microscopy room, while the noise of an alarm might be lost in 
the nearby sounds of a centrifuge, multiple biological hoods with loud fans, and a noisy heating unit. 
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To create this visual indicator, it was first necessary to determine of the voltage requirements of 
an available, but undocumented, red light-emitting diode. Brief experimentation demonstrated that two 
AA batteries, in series, were sufficient to meet the power requirements and cause immediate noticeable 
luminosity, particularly in the darkened room where imaging occurs. This corresponded to a voltage of 
about 3V. A series of variously valued resistors were also added in series to the circuit. It was empirically 
determined that a 300Ω resistor was the component with the greatest resistance that still allowed a 
bright response from the visual indicator. This resistor was included because in the absence of a load 
resistor, diodes quickly burn out. 
The electrical components were connected in series and in the proper relative orientations by 
twisted lengths of copper wire and electrical tape. This can be seen in Figure 34C. While solder would 
have been a preferable method of connection, material constraints forced the use of less sophisticated 
methods. 
The key section of the design, however, was the large electrical switch, located at the top of the 
solution reservoir. The mechanical components of this switch were based around a thin piece of semi-
rigid plastic fiber. One end of the fiber was tied to the tube, while the other was connected to a platform 
consisting of pieces of black polyurethane (the hobbycolor material described in the Section 4.4.1). The 
black section could freely slide onto and off of an overhang on the top of the syringe. Taped to this 
tubing was a piece of wire. This wire was electrically connected to the positive terminal of the batteries 
by a thin and flexible aluminum wire. On the opposite flange of the syringe was wrapped a piece of 
aluminum foil. This was connected to the negative terminal of the light-emitting diode. A small loop of 
wire was used to help the rising and falling piece of rigid wire stay aligned. Testing of this design was 
detailed in Section 5.1.2.The assembly can be seen in Figure 34D, E, and F. 
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4.4.5 Beta Design 
 
 
Figure 35: Computer model of the beta design; two plastic components fit over the top of the thermal control ring, holding 
the perfusion inflow and outflow micropipettes in steady positions relative to the slide chamber with the light shield placed 
over the component. 
 
The beta design utilized the best features of each of the previous prototypes. First, it featured 
the most complete light shield of any of the designs, utilizing the appropriate diameter found in 
prototype three. The use of 3D printing allowed us to have holes exactly as large as needed to accept 
the micropipette tips, but no larger, minimizing light which entered into the system. This degree of 
precision was not achievable with any previous manufacturing technique. 
Second, both the perfusions inflow and outflow of the system were based on micropipettes, 
rather than based on inconsistent flexible tubing. The micropipettes used as inflow and outflow were 
fixed in place by superglue to ensure consistent patterns of flow and volume of liquid. 
One potential concern was that the low diameter of the end of the inflow might cause a jet of 
high velocity water to enter into the system, which could potentially have caused cell shearing. 
However, the exact position of the inflow micropipette was chosen so as to make this impossible. Since 
the outflow pipette tip contacted the top surface of the water to ensure a consistent volume in the slide 
chamber, the inflow was placed approximately 2mm from the slide. This ensured that drops of fluid still 
gently rolled down the side of the slide chamber, as in the original perfusion system. 
A guide, located at a slight angle away from the inflow, allowed for the injection of any test 
solution without the need for any particular degree of manual dexterity. While attempts were made for 
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this input to be more accessible to left-handed users, no angle existed which did not cause either a 
mechanical interference or require a user’s arm to be held at an awkward angle. 
 
 
Figure 36: Interior View of bottom section of the Beta Design; on left and right, holes and guided channels allow for the 
introduction of perfusion inflow and outflow components into the slide chamber, as well as stabilize that allowed for direct 
injection of test solutions via micropipette. 
 
The printing of the device as two components was for manufacturability purposes. 3D printers 
generally print plastic components using two materials. There is both the material used for the 
structural components of the part itself, and a “matrix” material, which fills the vertical space below 
solid parts of the components. Printing in two parts used a minimum of matrix material, as the only 
locations in which it would be needed are the holes which allow for micropipette entry. This lowered 
production time and costs to the printing facility, which were both beneficial outcomes. At the time of 
final assembly, these two sections would permanently glued together into the configuration seen in 
Figure 35. 
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4.4.6 Modifications to Beta Design 
The CAD model was converted into a stereolithography file and printed in 3D by a MakerBot® 
type 3D printer, available for free student use at the International Centre for Theoretical Physics in 
Trieste, Italy. Printing of the beta design was successful, resulting in components virtually 
indistinguishable from the CAD models. 
 
 
Figure 37: The printed beta design; (A) the two parts of the device after removal from the 3D printer, and (B) the superglued 
and assembled beta design, mounted on top of the thermal control ring 
 
Although largely successful, a few problems were uncovered with the design, mostly related to 
the addition of the micropipette tips for the perfusion inflow and outflow systems. The existing holes in 
the side of the device did not allow micropipette tips to be placed at the appropriate locations relative 
to the slide. Both holes had to be drilled out to a wider diameter, to allow for clearance at the proper 
angle. This process was advantageous in terms of the stability of the design, as it allowed the 
micropipette tips to be secured by superglue to both the top and bottom edges of the holes. 
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Figure 38: Expanded holes in the side of the printed components, allowing for insertion of the micropipette tips in the proper 
locations; (A) the drilled out hole for the perfusion inflow, and (B) the drilled out hole for the perfusion outflow 
 
Second, the micropipette tips extend below the bottom plane of the device. This causes no 
issues while the device is inserted into the microscope, as the tips rest inside the slide chamber. 
However, on flat surfaces, the micropipette tips are the first components to contact, making them 
susceptible to damage. This can be prevented so long as the device is stored upside-down when not in 
use. Markings to this effect were added to the outside of the structure. Additional markings included 
explicitly declaring the in and out perfusion systems and giving a measurement line to help with the 
injection of the test solution. 
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5 Design Verification 
Each of the four designs discussed in Section 4.2 were considered as a solution to the 
engineering challenge. The chosen design was created and tested in the laboratories at the University of 
Nova Gorica. After generating these design alternatives and considering the results of the Design 
Evaluation Matrix (Table 5), the open perfusion system was decided upon as the most viable of the four 
alternatives.  In order to verify whether the beta design addressed the objectives, functions, and 
constraints established in Chapter Three, the team used a variety of experimental tests and procedures. 
The testing process, materials and methods are discussed in this chapter. 
 
5.1 Verification Experiments 
Compliance to the specifications was established through a series of seven design verification 
test experiments. Each of these experiments tested one or more related specifications. 
 
5.1.1 Mechanical Interference 
The purpose of the first experiment was to ensure the device could be set up, secured, used, 
and taken down without mechanically interfering with the microscope or damaging cells (Appendix E). 
The device was placed atop the thermal control ring and secured, where it independently remained in 
place. Tubing was connected to the perfusion inputs and outputs, and the microscope arm lowered 
without mechanical interference. All of these actions were completed within 10 minutes. An initial DIC 
image was captured, and time-lapse calcium imaging began prior to injection of TTX into the culture. The 
injection of TTX required a surprisingly high degree of dexterity, as it was difficult to guide the pipette 
directly into the culture through the small hole in the side of the device. Imaging was stopped and the 
time-lapse data evaluated. No interference with image quality was detected during the time of test 
solution injection. A DIC image was taken after perfusion was turned off. When compared to the original 
image, no cell damage was detected. Device disassembly required less than 10 minutes time. 
 
5.1.2 Low Fluid Alarm 
This experiment tested the effectiveness of the Low Fluid Alarm (Appendix F). The Low Fluid 
Alarm (detailed in Section 5.1.2) was tested by pouring a large amount of water into the reservoir, then 
switching the valve to the ‘open’ position and allowing the system to drain. The light-emitting diode 
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remained off until the solution reached a critically low level. The light-emitting diode indicated that 
experimenters needed to refill the reservoir, ensuring that data would not lost due to cellular exposure 
to air. 
 
5.1.3 Perfusion Effectiveness 
This experiment tested the device’s ability to track changes in concentration as a function of 
time (Appendix G). In order to do this, the team decided to utilize a spectrophotometer. A 9x 2:1 serial 
dilution of 2X Bromophenol Blue ink was prepared in a series of nine cuvettes, whose optical densities 
were recorded at a wavelength of 590 nm5 to create a standard curve. Next, the cell culture dish was 
filled with 100% dye and the perfusion system turned on. At 4 second time points, 15µL samples were 
taken and inserted into new cuvettes. The optical densities of these cuvettes were measured by 
spectrophotometer. The equation calculated to infer the concentration of dye as a function of time was 
determined to be Concentration (M) = 167.7exp(-0.285*tElapsed)). The equation implies an exponential 
decay of dye concentration. Based on this equation, after five minutes, the concentration would be 
reduced to a small enough level to conclude that the perfusion system effectively flushes out test 
solutions from the culture. 
 
5.1.4 Consistent Inflow and Outflow Positions 
This experiment determined whether or not the relative positions of micropipette tips of the 
perfusion inflow and outflow system were stable (Appendix H). In order to check that these positions 
remained constant, the distance between micropipette tips was measured with calipers as 15.85mm. 
The device was then shaken vigorously and measured again with calipers, this time measuring 15.64mm. 
Since the difference between the two values was 210 microns and this is likely within the range of 
measurement error, this provided strong evidence that the positions of the micropipette tips were 
constant, relative to one another. 
 
  
                                                          
5
 This frequency was chosen as it is near the peak of the absorption spectrum of Bromophenol Blue 
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5.1.5 Thermal Control Compatibility 
This experiment tested whether it is possible for the thermal regulation equipment to be used in 
conjunction with the device (Appendix I). The thermal control ring of the microscope has two plug-ins, to 
which a separate system must be connected to ensure temperature control over the course of a test. 
The device did not restrict access to these plug-ins.  
 
 
Figure 39: Plug-ins of the thermal control ring; note that the device does not prevent the connection of the thermal control 
ring to the external thermal control system 
 
5.1.6 Constant Volume 
This experiment tested whether the volume of liquid left in the slide remained constant 
between tests (Appendix J). Fluid volume variation was determined by covering the slide with 1mL of 
water, turning on the perfusion outflow pump, and waiting until the volume was constant with respect 
to time. When a stable volume was reached, the pump was turned off and a micropipette was used to 
remove incremental volumes of water until the slide chamber was empty. This test was repeated nine 
times, and yielded an average volume of 200µL with a standard deviation of 24.13µL. The results of this 
experiment surprised UNG researchers, who previously understood the chamber volume to be 500 µL. 
This implied that they had been exposing cells to higher concentrations of drug treatments than 
intended, as the positions of the perfusion outflow tubes are similar in both the old setup and in the 
device. 
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5.1.7 Light Blocking Capability 
This experiment tested whether the device would interfere optically with the quality of 
fluorescence imaging by allowing significantly more ambient light into the system than the previous 
setup. The protocol for this experiment can be found in Appendix K. With only distilled water over the 
slide, the background light which eventually reached the camera was tested under three conditions: 
with nothing blocking the light, with the previous setup (described in Section 2.4.2) blocking the light, 
and with the device blocking the light. The data from the three conditions was analyzed and compared. 
It was observed that while both light blocking techniques performed significantly better than an exposed 
system, neither showed a significantly greater capability to shield light than the other. 
 
5.1.8 Individual Specification Verification 
Below are listed all of the individual specifications of the design, as well as the deterministic 
questions which allowed the team to decide whether or not the specification was satisfied. 
 
Table 6: An overview of the state of completion of the various specifications 
ID Specification Deterministic Questions Validated? 
001 
At no point during 
the process of cell 
installation or 
testing shall the 
cell-carrying 
surface of the slide 
be exposed to air 
At any point in the 
completion of Protocol A, 
were the cells exposed to the 
open air? 
 
 Yes      ■ No 
 
If no, then the specification is 
validated 
 
■ Specification Met   
 Specification Not Met 
 
002 
Device must alert 
the user before 
running out of the 
control solution 
In Protocol B, is the answer 
to step 2 “No,” indicating the 
Low Fluid Alarm does not 
report a false positive result 
for low fluid level in the 
reservoir? 
 
■ Yes       No 
Is the answer to step 6 “Yes,” 
indicating that Low Fluid 
Alarm correctly reports 
■ Specification Met   
 Specification Not Met 
 
 65 
  
critically low levels of fluid in 
the reservoir? 
■ Yes       No 
If both answers are yes, then 
the specification is validated 
003 The control 
concentration of 
test solution must 
be +/- 1 mM the 
expected value 
initially 
Self-Evident. The initial 
concentration of the test 
solution is defined by the 
composition of the control 
solution. It will always be 
zero. 
■ Specification Met   
 Specification Not Met 
 
004 
The experimental 
concentration of 
test solution must 
be +/- 1 mM the 
expected value 
Are any of the values found 
in Protocol F, step six greater 
than 0.20mL away from the 
mean average of the ten 
values, indicating that 
concentration variance of 
greater than 1mM could be 
due to volume fluctuation?  
 
■ Yes        No 
If no, than the specification is 
validated. 
 
 Specification Met   
■ Specification Not Met 
 
005 
The final 
concentration of 
test solution must 
be +/- 1 mM the 
expected value 
Refer to the equation in step 
18 of protocol C. This 
equation defines the 
relationship between 
concentration and time in the 
perfusion system. Based on 
this equation, how long 
would the system require to 
drop below the 1mM level? 
 
Extrapolating from the 
collected data, the time 
required to reduce the 
concentration from 1 M to 
1mM is 24.28 seconds. 
 
Is this time less than five 
minutes, indicating that the 
test solution may be flushed 
from the slide within a 
reasonable time frame? 
■ Specification Met   
 Specification Not Met 
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■ Yes        No 
If yes, than the specification 
is satisfied. 
 
006 
No part of the 
device must 
mechanically 
interfere with any 
part of the 
operation of the 
microscope 
In protocol A, are the 
answers to steps six and 
seven both “No,” indicating 
that the microscope arm 
does not interfere with the 
light shield? 
 
■ Yes       No 
 
In protocol E, is the answer 
to step three “No,” indicating 
that the device does not 
interfere with the plug-ins of 
the thermal control ring? 
 
■ Yes       No 
 
If both answers are yes, than 
the specification is validated 
■ Specification Met   
 Specification Not Met 
 
007 
No part of device 
setup, operation, 
or breakdown must 
depend on an 
unusual degree of 
manual dexterity 
Are any issues with manual 
dexterity observed in 
Protocol A steps 5, 13, or 18? 
 
■ Yes       No 
If no, then the specification is 
validated 
 
 Specification Met   
■ Specification Not Met 
 
 
008 
No device 
component shall 
intrude upon the 
space between the 
slide and the 
objective lens 
In protocol A, step five, was 
there any interference with 
the space between the slide 
and the objective lens? 
 
 Yes      ■ No 
If no, then the specification is 
validated 
 
 
■ Specification Met   
 Specification Not Met 
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009 
The device shall be 
stable enough such 
that falling over 
and detachment 
are not concerns of 
experimenters 
At any point in the 
completion of protocol A was 
either knocking over or 
detachment of the device an 
issue? 
 
 Yes      ■ No 
If no, then the specification is 
validated 
 
 
■ Specification Met   
 Specification Not Met 
 
010 
The device shall 
take an 
experimenter less 
than ten minutes 
to fully set up 
Is the noted time in protocol 
A, step five less than ten 
minutes, indicating that the 
device was set up in less than 
this amount of time? 
 
■ Yes       No 
If yes, then the specification 
is validated 
 
■ Specification Met   
 Specification Not Met 
 
011 
The device shall 
take an 
experimenter less 
than ten minutes 
to fully break down 
Is the noted time in protocol 
A, step eighteen less than ten 
minutes, indicating that the 
device was fully broken down 
in less than this amount of 
time? 
 
■ Yes       No 
If yes, then the specification 
is validated 
 
■ Specification Met   
 Specification Not Met 
 
012 
The introduction of 
the test solution 
and microscopy 
must not be 
mutually exclusive 
events 
Was it possible to inject the 
TTX in protocol A, step 13, 
indicating that injection of 
test solution can be 
simultaneous with 
fluorescent imaging? 
 
■ Yes       No 
If yes, then the specification 
is validated 
 
■ Specification Met   
 Specification Not Met 
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013 
The speed and type 
of flow caused by 
the device must 
not damage or 
disturb the 
network of 
hippocampal 
neurons 
Compare the images taken at 
the five XY coordinates noted 
in protocol A, step eight 
between step eight and step 
sixteen. 
 
Are all neuron noted in step 
eight still present at the time 
of step sixteen?  
 
 Yes      ■  No 
If yes, then the specification 
is validated 
 
 Specification Met   
■ Specification Not Met 
 
 
014 
Any inflows and 
outflows to the cell 
culture must 
remain at constant 
positions relative 
to one another and 
to the slide from 
test to test 
Are comparable distances 
noted in Protocol D, steps 
one and three, indicating that 
the micropipette tips do not 
move? 
 
■ Yes       No 
If yes, then the specification 
is validated 
 
■ Specification Met   
 Specification Not Met 
 
015 
The temperature of 
the cells must be 
kept within 1 
degree Celsius of 
any desired 
temperature 
between room 
temperature and 
40 degrees Celsius 
Was the answer to protocol 
E, step three “yes,” indicating 
that it is possible to connect 
the thermal control system? 
 
■ Yes       No 
If yes, then the specification 
is validated 
 
■ Specification Met   
 Specification Not Met 
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6 Discussion and Results 
UNG’s Centre of Biomedical Sciences and Engineering at Vipava studied the mechanism of 
interaction between QDs and hippocampal neurons in order to explore the possibility to use them to 
evoke action potentials in single neurons. 
 
6.1 Device Implementation 
The beta design of the device was used in calcium imaging experiments to validate its 
effectiveness and viability to gather data and further research interests at the Centre. Initially, the 
device was used in experiments with well-understood test solutions containing Textradotoxin (TTX) and 
Gabazine. 
TTX, a neurotoxin derived from puffer fish, is a drug known to block sodium ion channels. Since 
sodium ions initiate the depolarization of action potentials, blockage of the sodium ion channels 
significantly decreases neuronal electrical activity. Two-dimensional time-lapse calcium images of 
neurons injected with 5µL of TTX were taken with both the original and new perfusion setups. In each 
case, the activity of cells decreased, as seen in Figure 40. 
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Figure 40: Calcium imaging of multiple neurons, each a different color, with TTX and perfusion system; (A) control series 
shows the basic activity of the network, (B) immediately after the addition of TTX, when activity stops, (C) perfusion system 
is opened, the first calcium event is witnessed after 47 seconds (D) 150 seconds after the perfusion is opened, the culture is 
actively firing again at almost the same magnitude as the control, indicating little photobleaching. 
 
When perfusion was turned on and TTX flushed away, activity returned after 5 minutes( Figure 
40D). Additionally, the similarity between the magnitude of signal in these tests suggests that the effect 
of photobleaching on OGB is negligible even with repeated long-term exposures. Both the new 
perfusion system, as well as the old, successfully diluted the culture solution enough for cells to regain 
activity in five minutes. 
Gabazine, an excitatory neurotransmitter discussed in Section 2.2.2, is known to elicit 
synchronous action potentials by inhibiting chlorine ion flux across the cell membrane. Since chlorine 
ions lower the membrane potential, the inhibition of chlorine results in only excitatory stimulus. 2D 
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time-lapse calcium imaging confirmed this outcome, as 5µL of 10µM Gabazine elicited increases in 
synchronicity and magnitude when injected into the culture (Figure 41).  
 
 
Figure 41: Calcium imaging of multiple neurons, each a different color, with Gabazine and perfusion system; (A) control 
series shows the basic activity of the network, (B) activity immediately after the addition of Gabazine, with large increases in 
the magnitude and synchronicity of activity, (C) activity just after the perfusion system is opened, with immediate decrease 
in activity (D) 150 seconds after the perfusion is opened, the activity of the culture significantly reduced, although still 
somewhat synchronous. 
 
Similarly to TTX, turning on the new perfusion system caused the effects of Gabazine to diminish 
overtime as it was washed away. Specifically, the results show decreasing synchronicity and overall 
occurrences of action potentials (Figure 41C). However, in this experiment, the photobleaching effect 
cannot be ruled out as error as in the TTX perfusion experiment, because the final test has such low and 
inconclusive signal. 
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6.2 Quantum Dot Experimentation 
After the device’s effectiveness in experiments was validated using TTX and Gabazine, 
experiments using Quantum Dots (QDs) were run to begin gathering new data. In Vipava, researchers 
used the Qdot-655 by Invitrogen, a division of Life Technologies. Previous research had shown, as 
discussed in Section 2.3, that when QDs were excited by radiation, they exhibited an electric dipole 
moment, or local change in voltage, which induced action potentials in neurons. The Qdot-655 was a 
CdSe-core, ZnS-shelled quantum dot with a polyethylene-glycol (PEG) surface coating (Figure 7). These 
QDs had a peak emission wavelength at 655nm, which was in the red spectrum of light and a broad 
excitation spectrum between 400nm and 750nm (Figure 9). Some Qdot-655 had additional biomolecules 
attached to their PEG surface coating to allow for specific biomolecule binding. UNG researchers 
conducted tests using Qdot-655 conjugated with both streptavidin and carboxyl (COOH-) functional 
groups. 
Streptavidin Qdot-655 have been used to conjugate to biotin proteins, allowing further 
conjugation to antibodies for targeted delivery in living systems. However, researchers at UNG did not 
conjugate Qdot-655 with any other biomolecule for experiments. When Qdot-655 was imaged using 
multi-plane 3D reconstruction imaging, the QDs showed slight adherence to the membranes of neurons, 
although most remained suspended in solution. A control calcium recording was taken which 
demonstrated spontaneous fluctuations, as shown Figure 42A. Upon injection of Streptavidin Qdot-655, 
the synchronicity of the culture increased dramatically, meaning each neuron was firing in phase, while 
the magnitude of electrical activity from individual neurons slightly decreased. 
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Figure 42: Calcium imaging of multiple neurons, each a different color, with 0.8nm of Streptavidin QD-655, (A) a control 
recording, showing spontaneous activity with different magnitudes in different neurons, and (B) recording after introduction 
of QDs, with increased synchronicity and decreased magnitude of activity. 
 
Together, the streptavidin protein and the PEG surface coating was a relatively large complex 
conjugated to the Qdot-655 in comparison to the size of the nanoparticle, as seen in Section 2.3. This 
large barrier could have shielded the electric dipole moment of the QD and prevented its efficient 
interaction with ion channels on the cell membrane.  
Carboxyl-coated (COOH-) Qdot-655s are reactive, organic biomolecules that served as a 
foundation for conjugation to more complex molecules, such as Streptavidin. A 2D time-lapse calcium 
image of these QDs in neuron culture revealed that the QDs strongly adhered to the cell membrane of 
neurons. A 3D reconstruction was created in order to confirm this hypothesis, as seen in Figure 43.   
 
 74 
  
 
Figure 43: A 3D reconstruction of carboxyl-coated Quantum Dots (red) attached on the cell membrane of hippocampal 
neurons treated with Oregon Green BAPTA (green) to show intracellular calcium. 
 
The inside of the neuron was loaded with OGB dye, which fluoresced around 488nm, illustrating 
the most calcium rich areas of the cell. Carboxyl-coated Qdot-655 fluoresced around 655nm and 
attached to the soma, dendrites and axons of the neurons.  
2D calcium imaging time-lapses were recorded of Carboxyl-coated Qdot-655 interacting with 
neurons. In the control recording, the calcium activity of the neuron was spontaneous. When Carboxyl-
coated Qdot-655 were injected into the culture, the calcium events became more synchronous, with the 
calcium events in some neurons much stronger. Additionally, the intensity of calcium activity in each 
neuron became more equivalent. 
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Figure 44: Calcium imaging of multiple neurons, each a different color, with 0.8nm of carboxyl-coated QD-655, (A) a control 
recording, showing spontaneous activity with different magnitudes in different neurons, and (B) recording after introduction 
of QDs, with increased synchronicity and equivalent magnitudes of activity. 
 
In order to understand the mechanism of interaction of between Qdot-655 and neurons using 
calcium imaging, additional experiments were conducted to compare to QD experiments using drugs 
with known and well-characterized effects on neuronal electrical activity. A time-lapse calcium recording 
was performed with Gabazine to compare with the QD interaction, as seen in Figure 45. In the control 
recording (Figure 45A), calcium activity was low.  
 
 
Figure 45: The effect of Gabazine on neuron cultures, (A) a control recording shows weak, spontaneous activity, and (B) after 
the introduction of Gabazine, recording shows increased magnitude and synchronicity of activity. 
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Notice that when Gabazine was introduced into the culture, calcium activity increased in both 
synchronicity and magnitude. These results show that carboxyl-coated QDs interacted with neurons to 
cause similar synchronous activity to Gabazine.  
Finally, a validation experiment was conducted with a combination of Qd-655 and TTX. TTX can 
be used to rule out secondary calcium signals as the source for activity in calcium imaging, as seen in 
Figure 46. 
 
 
Figure 46: The effect of TTX on calcium activity of hippocampal neurons stimulated by carboxyl-coated QD; with calcium 
signals affected by QDs seen highlighted in red and, the lack of calcium activity as a result of TTX seen in blue. 
 
Carboxyl-coated Qdot-655 was introduced into a network of neurons and caused synchronous 
activity. Then, TTX was introduced midway through the recording and most calcium activity stopped. 
This implies that the majority of the calcium signals recorded resulted from the electrical activity of 
neurons. 
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6.3 Design Considerations 
As with any design, there is a pressing need to discuss its social impact. Whether it is a global 
consideration or a local concern, the following section analyzes the impact of this project on the 
surrounding world.  
 
6.3.1 Economic Impact 
If this drug delivery platform is successful, the University of Nova Gorica will economically 
benefit. The device will inject drug treatments directly into cell culture, rather than into the solution 
reservoir, maximizing the efficiency of the drug delivery process, as treatments are not lost in the 
perfusion tubing. This increased effectiveness will therefore decrease the amount of money UNG spends 
on various drug treatments and nanoparticles.  
 
6.3.2 Environmental Impact 
The 3D printing process wastes material, as it has a filler polymer that must be cut out before 
the final design can be printed. Additionally, UNG uses Cadmium core QDs, which contain heavy metals 
that are known to be toxic to living systems and dangerous to the environment if not disposed of 
properly.  
 
6.3.3 Societal Influence 
The research at UNG deals with neuroplasticity, important in memory formation. QDs have been 
shown to alter the plasticity of neurons, which can be used to stimulate neurons and study 
neuroplasticity in vivo. By increasing the efficiency of experiments, our device will help to further 
knowledge in a groundbreaking field of neuroscience. Understanding the external effects of materials 
and chemicals on hippocampal neuron cultures will better elucidate the working of the human brain.  
 
6.3.4 Political Ramifications 
Students from the United States of America created a design to be used by Italian researchers at 
a Slovenian laboratory. This multicultural environment requires the cooperation of Slovenian, Italian, 
and American governments.  
 78 
  
 
6.3.5 Ethical Concerns 
The ethical concerns of our design are limited to the usage of non-sustainable plastic materials, 
as well as waste of 3D printer polymer filler. Additionally, the use of Cadmium core QDs may be of 
concern, as Cadmium is a toxic heavy metal that may be harmful to the environment. 
 
6.3.6 Health and Safety Concerns 
The fluorescence feature of the Olympus microscope used at UNG emits ultraviolet radiation 
that may significantly damage vision after prolonged exposure. Our device includes a light shield that 
blocks the microscope operator’s eyes from harmful UV light. The test solutions used in experiments are 
potentially harmful, as Gabazine has been known to cause epilepsy and Tetradotoxin is known to have 
powerful neurotoxic properties. 
 
6.3.7 Manufacturability 
Our device is detailed in SolidWorks and may be easily manufactured using 3D printing. This 
allows for future modifications and reproduction of the device. Additionally, all other components can 
be procured for low costs in bulk, making larger scale production feasible. 
 
6.3.8 Sustainability 
The perfusion system itself requires no energy to operate, although the Low Fluid Alarm is 
powered by two AA batteries. Additionally, the microscope and perfusion outflow pump both require 
electricity to function. The final product is minimalistic and uses materials already existent in the 
laboratory. 
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7 Final Design and Validation 
Research at the University of Nova Gorica requires coordination between a variety of different 
systems and procedures. First is the Olympus microscope, capable of capturing fluorescence and DIC 
images with sub-micrometer resolution. Images of cells are processed and crucial data is derived from 
these results. In between the microscope and the data is the perfusion system, which provides 
necessary nutrients to maintain cell health and introduces various treatments into the culture. The 
original perfusion system at UNG was both unwieldy and inefficient, so the team set out to improve 
upon the treatment delivery and the convenience of the system. 
 
7.1 Design Workflow 
A Gantt chart (Appendix C: Gantt Chart) and a work breakdown structure (Appendix B: Work 
Breakdown Structure ) were created to describe all tests to run and data to acquire over the course of 
the team’s time at UNG. In order to ensure the device would not mechanically interfere with the 
microscope, dimensions were measured and used to produce computer aided design (CAD) drawings of 
design alternatives. Upon completion of CAD drawings, the group visited a local hardware store to 
purchase necessary materials, and created the first prototype from polyurethane. The first prototype 
had dimensions which interfered with the microscope components and prevented imaging when placed 
onto the thermal control ring. A second prototype was constructed primarily using Plexiglass, rather 
than polyurethane, as the primary material, and aluminum cans were used to manufacture a 
rudimentary light shield. This prototype was functional; however, the diameter of the light shield 
mechanically interfered with the arm of the microscope and inhibited the movement of the microscope 
stage, preventing imaging of all areas of the slide. To alleviate this issue, a final prototype design was 
manufactured out of the same materials as the second, which was demonstrated to have no mechanical 
interference with the microscope components.  
The final CAD drawing was sent to be 3D printed at another facility. The printed device was 
comprised of two separate components and made of ABS, a thermoplastic polymer with a glass-
transition temperature of 1050C, much higher than the maximum experimental temperature of 370C 
experienced on the microscope. After gluing the two components together, micropipette tips and tubing 
were set with glue, and the device was used in experiments. A final addition to our device was a Low 
Fluid Alarm for the perfusion system. This alarm activated a small light-emitting diode next to the 
computer screen to inform the experimenter of the need to refill the reservoir with solution. 
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7.2 Design Assembly 
Using SolidWorks 2012 x64 Edition computer modeling software, two 3D models were created. 
The first of these models incorporated mounts for the later addition of perfusion system components 
and a guidance system to increase the ease of injection of test solutions into the sample. The bottom of 
this part was shaped to fit over the thermal control ring of an Olympus IX81 inverted microscope 
without mechanically interfering with any microscope component. A hole in the bottom of this 
component allowed for clear light paths to both the microscope arm above the sample and to the 
objective lens below.  
The second of these models was shaped to fit on top of the first and extend as far as possible 
upwards without resulting in mechanical interference. This component prevented large amounts of 
ambient light from reaching the slide. 
These components were converted to .STL files and sent to the 3D Printing Laboratory at the 
International Centre for Theoretical Physics (ICTP) for printing. They were successfully printed out of 
orange ABS plastic. The matrix polymer was removed from both components. The second of the 
components was superglued on top of the first to combine them into a single device. 
Micropipette tips were connected to thin rubber tubing and inserted into the mounts on either 
side of the device. The tips of these micropipettes were positioned such that, when the device was 
placed in the microscope, the outflow tip was in contact with the edge of the slide in the chamber and 
the inflow tip recessed approximately 2 mm back from the edge on the opposite side. This positioning 
required drilling out two holes in the side of the device to a greater area. Once positioned, the 
micropipette tips were superglued into place. 
Separately from the above, an indicator system was created to alert the user of a critically low 
level of control solution in the perfusion inflow system. Three pieces of 3mm black polyurethane were 
cut to size and glued together, such that they fit over a flange of a Henke Sass Wolf Norm-Ject 60mL 
syringe. A microcentrifuge tube was filled with enough stones so that it had just enough buoyancy to 
remain floating in 370C water, while still having the greatest possible mass. This tube was connected to 
the black polyurethane piece by a length of plastic fiber, such that when the polyurethane was fitted 
over the flange, the centrifuge tube hung down inside the syringe to a height of between ½ and 1 inch 
from the bottom. 
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The opposite flange of this syringe was covered with a layer of aluminum foil, attached on the 
inside by superglue. Thin wiring was connected to the plastic tubing and the polyurethane piece to form 
a simple electrical switch across the top of the syringe. This switch remains naturally open when the 
syringe is filled with fluid, but closes when it is not. This switch was placed in series by long lengths of 
copper wire with a 300Ω resistor, a red light-emitting diode of unknown origin, and two AA batteries. 
 
7.3 Financial Considerations 
While the team was able to manufacture the existing design using entirely free or available 
materials, production of future versions would likely not be equally inexpensive. The primary cost of the 
design is due to the 3D printing process. 
There is no realistic alternative to 3D printing for production of these parts, particularly 
considering the limited manufacturing facilities available to the Centre for Biomedical Sciences and 
Engineering. While the team was able print at no charge, thanks to the support of Carlo Fonda at ICTP, it 
is presumptuous to assume that ICTP would continue to offer its free services in the future. However, 
various companies exist which can print in 3D for little more than the price of materials. The price of 3D 
printing was estimated using the website 3Dprintingpricecheck.com. The light shield component could 
printed by several companies for approximately €7.26 ($10), while the perfusion component could be 
printed for approximately €10.89 ($15), totaling approximately €18 ($25) to 3D print the design using 
ABS plastic. 
Micropipette tips, which serve as the perfusion inflows and outflows, are readily available in 
excess in the laboratory. In most cases, after a single use for other applications, they would be 
discarded. As the pipettes for this design do not necessarily need to be biologically sterile, they may be 
repurposed from tips that would otherwise be thrown out and cost UNG nothing. The same can be said 
of the micropipette tube and aluminum foil required for the Low Fluid Alarm. 
Superglue is readily available at a convenience store approximately 50 meters from Centre for 
Biomedical Sciences and Engineering, where it costs €3.30 ($4.55).  
The thin plastic fiber used for the Low Fluid Alarm was purchased in bulk for €1.00 ($1.38). 
Tubing and tubing connectors are readily available due to proximity to the Slovenian Wine 
Research Institute, and added no additional cost to the design. Future tubing and connecters may be 
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purchased from Warner Instruments for less than €16.69 ($23.00) and €20.32 ($28.00), respectively 
(specialized tools for Electrophysiology and Cell Biology Research). 
A spool of insulated copper wire for the Low Fluid Alarm was purchased by the team for €6.50 
($4.72) at a local hardware store. The length of wire purchased is sufficient for dozens of additional 
designs, if desired or needed. 
Simple red light-emitting diodes can be purchased for less than € 0.36 ($0.50) each. 
Electrical tape can be purchased for less than €2.90 ($4.00). 
Even in low quantities, AA batteries may be purchased for no more than € 0.73 ($1.00) each. 
These prices reduce significantly when the batteries are purchased in bulk. 
A summary of the manufacturing costs is presented below: 
 
Table 7: Costs of all materials needed to manufacture the beta device 
Component Cost (Euro) Cost (USD) 
3D Printed Light Shield Free Free 
3D Printed Design Bottom Free Free 
Micropipette Tips Readily available Readily available  
Microcentrifuge Tube Readily available Readily available  
Plastic Fiber €1.00 $1.38 
Superglue €3.30 $4.55 
Tubing and Accessories Readily available Readily available  
Copper Wire €6.50 $8.95 
AA Batteries (2) €1.45 $2.00 
Electrical Tape €2.90 $4.00 
Hobbycolor Polyurethane €3.39 $4.67 
Red light-emitting diode €0.36 $0.50 
Total Cost6 €18.85 $25.97 
                                                          
6
 Calculated according to the US Dollar/Euro conversion rate of 16Dec2013 
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Table 8: Costs of all materials needed to manufacture any future devices. Copper wire and plastic tubing were purchased in 
large enough quantities that there exists enough excess for many future devices. Microcentrifuge tubes and micropipette 
tips can be easily procured from lab waste.  
Component Cost (Euro) Cost (USD) 
3D Printed Light Shield €7.26 $10.00 
3D Printed Design Bottom €10.89 $15.00 
Micropipette Tips Readily available from laboratory 
waste 
Readily available from 
laboratory waste 
Microcentrifuge Tube Readily available from laboratory 
waste 
Readily available from 
laboratory waste 
Plastic Fiber Readily available after bulk 
purchase 
Readily available after bulk 
purchase 
Superglue €3.30 $4.55 
Micropipette Tubing €16.69 $23.00 
Micropipette Connectors €20.32 $28.00 
Copper Wire Readily available after bulk 
purchase 
Readily available after bulk 
purchase 
AA Batteries (2) €1.45 $2.00 
Electrical Tape €2.90 $4.00 
Hobbycolor Polyurethane €3.39 $4.67 
Red light-emitting diode €0.36 $0.50 
Total Cost7 €66.56 $91.72 
 
These costs are considered acceptably low by both the team and the University of Nova Gorica. 
 
                                                          
7
 Calculated according to the US Dollar/Euro conversion rate of 16Dec2013 
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7.4 Device Verification Testing  
Calipers were used to measure the distance between the micropipette tips of the device. The 
device was shaken vigorously in an attempt to alter micropipette position and calipers were used to re-
measure the distance between tips.  
The device was placed on top of the thermal control ring, and thermal plug-ins were connected 
and disconnected from the ring. Perfusion tubing was secured to the micropipette tips and the 
microscope arm was lowered over the device. The pump was turned on and a DIC image was captured 
prior to turning the perfusion system on. The perfusion system was turned on and a time-lapse image 
was recorded. A second DIC image was taken after the perfusion system was turned off. 
The perfusion effectiveness was tested using spectrophotometry. The slide chamber was filled 
with 2X Bromophenol Blue ink. The perfusion system was turned on, and a 15µL sample was taken from 
the slide chamber at time points of four seconds. These samples were deposited into a series of nine 
cuvettes whose optical densities were recorded by spectrophotometer. The concentrations were 
plotted as a function of time using a standard curve of optical density as a function of concentration 
determined by a 9x 2:1 serial dilution of the Bromophenol Blue ink. 
The consistency of slide chamber volume was tested. The slide chamber was again filled and the 
outflow pump turned on to suction out excess fluid. When the volume in the slide chamber stabilized, 
the pump was turned off. A micropipette was used to remove the remaining liquid by 20mL increments. 
This test was repeated nine times.  
To determine the amount of ambient light entering the system, a slide of only distilled water 
was mounted in the slide chamber and fitted onto the thermal control ring. Two 15-second fluorescent 
images were taken for each of three light-blocking parameters: the installed device, a cardboard box 
surrounding the microscope, and no light shield. The average intensities of light in each of these three 
conditions were recorded and statistically compared. 
The Low Fluid Alarm was mounted on top the solution reservoir. Its effectiveness was tested by 
pouring 50mL of fluid into the reservoir while the perfusion inflow valve was closed. The perfusion 
inflow valve was then opened and the fluid was allowed to flow from the reservoir. The light-emitting 
diode was monitored for activity.   
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7.5 Experimental Validation Testing 
The effects of TTX, Gabazine, and QDs were studied using an identical test procedure. A neuron 
culture was viewed under a microscope and one glass slide was inserted into a petri dish containing 
1.5mL Ringer’s solution and 0.7µL OGB dye. The petri was covered with aluminum foil and left for 40 
minutes. Tweezers were used to remove the slide from the petri dish and place it into the slide chamber 
(Appendix L). The slide was submerged in Ringer’s solution and the slide chamber was fitted into the 
thermal control ring and placed onto the microscope setup. The device was secured onto the thermal 
control ring and the microscope arm was lowered. Perfusion tubing was attached to the micropipette 
tips protruding from the device. The perfusion outflow pump was turned on and the reservoir inflow 
valve was opened. 
The xenon lamp was powered up by first turning on the lamp, waiting for ten seconds, then 
turning on the main power supply. The microscope camera was turned on, and then Slidebook5 
software calibrated for use with the xenon lamp was opened. A new slide file was saved as the day’s 
date.  
A control DIC image was taken to identify the location of neurons. ROIs were drawn around each 
of the identified neurons in the field of view. Time-lapse fluorescent images were recorded to assess 
initial culture conditions. The perfusion reservoir valve was closed and a selected dose of test solution 
was injected into the culture via micropipette through the micropipette guidance hole.  A fluorescent 
time-lapse recording was begun immediately following treatment. Cell activity was visualized using a 
graph of the average intensity of each ROI as a function of time. The culture in test solution was imaged 
once or twice more, depending on experimental need. Once sufficient data was acquired, the reservoir 
valve was opened and a one-minute fluorescent time-lapse image of drug perfusion out was taken every 
two minutes.  
At this point, the experiments varied depending on the test solution in use. If the cells were still 
alive and showed only minor photobleaching, then the reservoir valve was again closed; a second test 
solution was introduced into the culture, and the experimental process was repeated. If the cells 
exhibited a significant amount of photobleaching, then the reservoir valve was closed and the pump 
turned off. The breakdown instructions Appendix M: Standard Operating Procedure for Breakdown of 
the Olympus Microscope were followed. Data analysis was performed using the MATLAB script of 
Appendix N: MATLAB Script used for Data Analysis and Presentation. 
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8 Conclusions and Recommendations 
The Centre for Biomedical Sciences and Engineering in Vipava is a new facility that could benefit 
from the presence of innovative engineering students, able to solve problems and implement 
improvements to laboratory experimental procedures and setups. Additionally, these refinements are 
intended to produce meaningful experimental data that is able to advance research in neuroscience and 
nanotechnology. 
As engineering students tasked with studying the mechanism of interaction between Quantum 
Dots (QDs) and hippocampal neurons, this project took on both a design and a research component. As 
such, the Conclusions and Recommendations will have both engineering and experimental facets. 
 
8.1 Engineering Design Conclusions 
1. Blocks ambient light during florescent imaging 
The Centre is a new facility and all available space has not yet been renovated. As a result, the 
current laboratory space can be congested at times. The microscope used for calcium imaging, a light 
sensitive procedure, is set up in this busy area. To improve this setup, the team designed a compact 
device to shield ambient light from the microscope. The device was easier to assemble and maneuver, 
as it did not require the experimenter to remove the existing cardboard light shield each time. 
Additionally, the device was less likely to contaminate the culture, as sometimes the cardboard 
deposited debris into the slide chamber. The device shielded the slide from light as well as the previous 
light shield, had a smaller profile, and was easier to handle than the previous technique. 
2. Maintains more consistent volume of solution in slide chamber 
The previous setup included movable perfusion inflow and outflow mounts that changed 
position between each experiment, making it difficult to maintain precise volumes of solution in the 
slide chamber. The new device had consistent inflow and outflow placement that improved the 
precision of volume in the slide chamber, but still had some variability. 
3. Removes 99% of test solution in under 30 seconds with perfusion 
Validation testing with TTX demonstrated that the device could restore control conditions and 
return calcium activity in cultures. The perfusion outflow appeared to reduce the concentration of test 
solution in the slide chamber to less than 1% in thirty seconds.   
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4. Signals to user when control solution is low 
The Low Fluid Alarm was used during QD experiments effectively alerted the experimenter 
when control solution levels were low. The light-emitting diode was bright enough to be seen in the 
darkened laboratory, and its use prevented culture damage due to exposure to air. 
   
8.2 Experimental Conclusions 
1. Quantum Dots work as an anti-IPSP agent 
As discussed in Section 2.2.2 and seen in Section 6.1, Gabazine produces synchronous activity in 
neurons because it blocks anion channels in the synapse that normally inhibit action potentials. In effect, 
Gabazine only permits excitatory potentials, meaning that when one neuron generates an EPSP above 
the action potential threshold, all connected neurons generate action potentials synchronously. As 
shown in section 6.2, the addition of QDs also elicited synchronous activity; when one neuron activated, 
the other neurons activated. Additionally, it has been shown that Quantum Dot only induce dipole 
moments very close (<20nm) to ion channels, as discussed in Section 2.3.2. Therefore, QDs work as anti-
IPSP molecules in the synapse, using a mechanism similar to that of Gabazine. 
2. Quantum Dots in solution may also work as anti-EPSP agents 
In addition to synchronous activity, cultures showed uniform amplitudes of calcium activity 
among all neurons after the addition of QDs. This effect is interesting and unexpected. As discussed in 
Section 2.4.1, different neurons in culture will typically show different levels of calcium activity with 
non-ratiometric dyes, due to different cell volumes and different intracellular accumulation of dye. This 
is considered to be one of the downfalls to using traditional non-ratiometric dyes, and prevents 
quantitative comparison between experiments.  However, as seen in Section 6.2, when QDs are 
introduced into cultures, all neurons exhibit uniform and generally decreased activity. Thus, uniform 
application of QDs in a culture, such as when applied in solution, acts similarly to an anti-EPSP drug that 
uniformly reduces the amount of activity in culture. 
3. Few QDs are needed to change activity in neurons 
Although Streptavidin-coated and carboxyl-coated QDs had the same final concentration 
(0.8nM) in culture, streptavidin-coated QDs did not adhere to the cell membrane as much as carboxyl-
coated QDs, as shown in Section 6.2. Not only were QDs present at the nanomolar concentration, but 
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also few Streptavidin QDs adhered to neurons. Therefore, an low number of QDs need to physically 
interact with neurons to elicit electrical activity. 
 
8.3 Engineering Device Recommendations 
1. The device should be black rather than orange 
If the team was not operating under a small budget in a new facility, more money could have 
been spent on materials. Orange ABS plastic was the cheapest for the ICTP to 3D print, but this color 
does not provide optimal light absorption. In the future, light shields should be made with non-glossy, 
black materials to minimize reflected ambient light from reaching the culture. 
2. Use microfluidic devices in perfusion system 
A more detailed investigation could be made into the fluid dynamics of the perfusion system on 
the microscope. Microfluidic devices can be manufactured at the Elettra Sincotrone in Trieste, Italy that 
would enable closed-system alternatives to be explored, as seen in Section 4.2.2. As discussed, closed 
systems have the benefit of only one source of pressure, highly tunable flow rates, and constant 
volumes, but are generally harder to manufacture. Additionally, microfluidic devices would allow 
accurate drug delivery with minimal waste of materials. With access to a manufacturing laboratory, 
closed-loop microfluidic systems could be developed cheaply and efficiently.  
3. Modify the opening for micropipette injection 
The device currently has a small opening that allows the insertion of a micropipette to inject 
drugs directly into the culture, as described in Section 5.1.1. While in theory, this component is a good 
method to deliver drugs, in practice the opening is hard to use with small volumes (0.2-2uL) of test 
solutions. The surface of the culture has to come into contact with the micropipette in order to release 
the test solution into the culture, requiring care and dexterity. In the next iteration of the design, a door 
should be made that would provide more visibility to the operator when injecting test solutions. This 
door should be accessible from both sides to accommodate right and left-handed individuals.  
4. Create a bright field illumination cap for the condenser on the microscope arm 
With the current device, there is only one remaining way for ambient light to enter the culture. 
On the microscope arm, there is a condenser that focuses brightfield white light during DIC imaging 
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before it shines on the culture, as seen in Figure 17B. In the future, an inexpensive, removable cover 
should be made for use during florescence imaging.  
5. Focus on standardization to better accommodate future international students 
Future research at UNG should be based on the idea of standardization of all test protocols. The 
Centre is less than a year old, but already is forging relationships with other universities and 
collaborating with students from overseas. In their early years, the Centre will confront issues of 
equipment setup, protocol refinement, material acquisition, and pressure for results. Care should be 
taken to document every step of processes, making the learning curve of new students much smaller. 
Overall, Standard Operating Procedures should be available for all typical lab activity, for the purposes 
of documentation, repeatability, and consistency. To this end, the has provided Standard Operating 
Procedures for many of the techniques needed to study QD-neuron interactions with calcium imaging. 
These procedures are documented in Appendices D, L, M, O, P, and Q. 
 
8.4 Experimental Recommendations 
1. Study the effects of fluorescence on QD-neuron interactions 
The existing setup at the Centre is limited to the study of QD-neuron interaction with calcium 
imaging. A more robust way to characterize the activity of neurons would be to correlate calcium 
activity in the network with electrophysiological recordings from individual neurons. With 
electrophysiological recordings, any wavelength and intensity of light can be used to excite the QDs, 
while preserving the ability to record their activity independently. 
Furthermore, the wavelength of light used to excite the calcium dyes also excited the QDs. In 
the case of OGB, the excitation wavelength was 488nm. This was not the peak excitation wavelength of 
Qdot-655 and may have impacted the strength of the induced dipole in the QD, which induces electrical 
activity in neurons. With a larger dipole moment, the QDs could elicit stronger neural signals. 
2. Refine protocols for ratiometric calcium dyes such as FURA-2 
Ratiometric dyes, such as FURA-2, respond to changing calcium levels in a cell by changing their 
peak florescence excitation wavelength. This allows a ratio of bound-to-unbound dye to be calculated 
during experiments, circumventing problems inherent in calcium imaging, including photobleaching and 
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uneven distributions of dye. Ratiometric dyes provide quantitative data that may be compared more 
confidently among experiments. 
Additionally, both FURA-2 and QD-655 are excited best in the UV range. This allows the most 
efficient excitation of QDs during calcium imaging, with the best chance of producing a strong dipole 
moment and eliciting electrical activity in neurons. 
3. Determine dose-response curves for different surface coatings of Qdot-655  
Dose response curves may be used to identify the most ideal concentration of Qdot-655 to 
stimulate neurons. Different surface coatings are expected to induce different levels of activity in the 
cells, but with varying levels of toxicity. 
4. Use optical tweezers 
A nearby laboratory in Trieste, Italy, used optical tweezers to localize large vesicles (1-10µm) to 
certain parts of neurons and release very precise concentrations of molecules. This can be used to study 
the interaction of one or more QDs with particular parts of the neuron, including the synapse, while 
limiting cell toxicity. Additionally, QDs can be visualized as they interact with neurons. 
5. Characterize effect of polymer/biomolecule coatings on dipole moments 
While the presence of PEG coatings and other biomolecules limited toxicity and provided 
functionality to the QDs, these coatings also serve as physical barriers to electric dipoles. To maximize 
the potential for QDs to stimulate neurons, the optimal balance of excitation wavelength and intensity 
can be paired with different surface to coatings in order to identify a nontoxic QD that has a strong 
dipole moment. This method might not require studying the QD-neuron interaction, but rather the 
Qdot-655 itself. 
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Appendices 
Appendix A: Original Statement of Client Needs 
 Below is listed the original declaration of UNG’s initial research for this project, provided to the 
team on 20 June 2013. 
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Appendix B: Work Breakdown Structure 
 At the outset of the project, the team determined a list of tasks which would need to be 
accomplished during the limited time at UNG.  
1. Design Process 
1.1.1. Initial client statement discussion 
1.1.1.1.1. Initial client/sponsor contact 
1.1.1.1.2. Generate questions on working environment 
1.1.1.1.3. Discuss need for design 
1.1.1.1.4. Generate questions for client/sponsor interview 
1.1.1.1.5. Propose equipment revisions 
1.1.1.1.6. Research neurobiology and microscopy 
1.1.2. Preliminary testing with current equipment 
1.1.2.1.1. Familiarize with equipment on site 
1.1.2.1.2. Develop current testing protocols 
1.1.2.1.3. Document sources of error and labor 
1.1.2.1.4. Perform laboratory testing with current design 
1.1.2.1.5. Propose new perfusion design 
1.1.3. Develop design alternatives 
1.1.3.1.1. Write Background 
1.1.3.1.2. Develop objectives tree 
1.1.3.1.3. Develop a function-means tree 
1.1.3.1.4. Current state of the field 
1.1.3.1.5. Previous research and perfusion options 
1.1.3.1.6. Brainstorm design alternatives 
1.1.4. Prototyping 
1.1.4.1.1. List materials, methods, budget for improving design 
1.1.4.1.2. Buy materials 
1.1.4.1.3. Build initial prototype 
1.1.4.1.4. Test prototype 
2. Documentations 
2.1.1. Contact 
2.1.1.1.1. Initial client introduction letter 
2.1.1.1.2. Agendas for meetings with sponsor 
2.1.1.1.3. Project Design Presentations 
2.1.1.1.4. Project Design Proposal 
2.1.2. Final presentation 
2.1.3. Research 
2.1.3.1.1. Annotated bibliography 
2.1.3.1.2. Detailed background 
2.1.3.1.3. Laboratory experimental notebook with data 
2.1.3.1.4. Experimental SOPs 
2.1.4. Design 
2.1.4.1.1. Design Notebook with CAD and code 
2.1.4.1.2. Experimental results and validation 
2.1.4.1.3. Final prototype and SOP 
3. Project management 
3.1.1. Files and Data 
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3.1.1.1.1. Organize and maintain electronic files 
Manage team communications 
3.1.1.1.2. Create and modify agendas 
3.1.2. Personnel 
3.1.2.1.1. Develop and maintain Gantt chart 
3.1.2.1.2. Schedule deadlines 
3.1.2.1.3. Schedule laboratory time 
3.1.2.1.4. Create and modify to-do lists 
4. Laboratory testing 
4.1.1. Inventory and stock materials 
4.1.2. Prepare cell culture medium 
4.1.3. Hippocampal cell passaging and maintenance 
4.1.4. Testing with current equipment 
4.1.5. Optimize ratiometric-imaging protocol 
4.1.6. Drug perfusion with ion blockers 
4.1.7. Treatment with Quantum Dots 
4.1.8. Testing with final design 
4.1.9. Data analysis 
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Appendix C: Gantt Chart 
 Below is a Gantt Chart, detailing the expected general timeline for completion of the various 
steps of the project. While the true timeline for tasks varied in several areas, it served as a roadmap  
 
 
Figure 47: A visual representation of work to be completed, as understood by the team at the outset of the project 
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Appendix D: Standard Operating Procedure for Staining Cells Prior to Imaging 
 This standard operating procedure describes the process by which cells are loaded with OGB dye 
prior to calcium imaging. 
 
Materials: 
1. Small (35 x 10 mm) Petri Dish 
2. Large (100 x 15 mm) Petri with Plated Cells  
3. Dye (Fura-2 or Oregon Green) 
4. Tweezers 
5. Ringer’s Solution 
 
Procedure: 
1. Pipette 1.5mL of Ringer’s Solution into small Petri dish 
Note: This should be just enough liquid to cover the bottom of the dish 
2. Add desired dye. This will be either 
a. 1.5uL Fura-2 
b. 0.7uL Oregon Green  
3. Remove tweezers from ethanol filled Falcon tube and allow to air dry 
4. Using tweezers, remove one glass slide from larger 4-slide Petri and place into the smaller dye-
Ringer’s Petri 
5. Cover small Petri with aluminum foil to avoid photo bleaching from the UV in the room 
6. Place larger Petri back to incubator 
7. Leave the small petri dish at room temperature for ~30 minutes for cells to absorb dye   
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Appendix E: Verification Protocol Testing for Mechanical Interference, Cell Shearing, and 
Issues of Manual Dexterity 
 This verification protocol was followed and completed to test compliance with specifications 
001, 006, 007, 008, 009, 010, 011, 012, and 013.  
 
Step User Instruction Documentation of Result 
1 Load a slide of networked cells (at least five DIV) with Oregon 
Green Dye, according to Appendix D: Standard Operating 
Procedure for Staining Cells Prior to Imaging 
N/A 
2 Image the cells under a visible light microscope Do the cells appear to be alive, 
viable and have formed a neural 
network? 
 
■ Yes       No 
 
3 Transfer the cells to the primary microscope. N/A 
4 Obtain a stopwatch or other timekeeping device N/A 
5 Using the stopwatch, determine the required amount of time 
for a user to set up the device. 
Total setup time: 
 
_0_ min  _44_ sec 
 
Did the user have any dexterity-
related issues with device setup? 
 
 Yes      ■ No 
 
Does the device mechanically 
interfere with or intrude upon 
the space between the slide and 
the objective lens? 
 
 Yes      ■ No 
 
6 Lower the microscope arm down to the imaging position Does the microscope arm 
mechanically interfere with the 
device? 
 
 Yes      ■ No 
 
7 Using the manual lever, move the imaged location of the 
slide to the top, bottom, left, and right extents of the slide.  
Does the microscope arm 
mechanically interfere with the 
device while imaging any 
location on the slide? 
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 Yes      ■ No 
 
8 Identify five distinct clusters of cell on the slide, all of which 
appear to be alive and networked. Note the XY coordinates 
of these five locations, and take a DIC image of each of them. 
Locations with Viable Cells: 
X1: 56.080    Y1: 46.514 
X2: 56.304    Y2: 46.514 
X3: 56.231    Y3: 46.185 
X4: 56.828    Y4: 46.439 
X5: 57.110    Y5: 46.078 
9 Begin perfusion of ringer’s solution over the cells N/A 
10 Identify a region of cells on the slide. This location may be 
one of the viable cell locations from step 8 
Chosen location: 
 
X: 57.193      Y: 46.078 
11 Begin an indefinitely long fluorescent time-lapse capture of 
this location 
N/A 
12 Stop the perfusion system N/A 
13 While continuing to image the region of cells, introduce TTX 
into the cell culture 
Were there difficulties related to 
the introduction of TTX to the 
cell culture? 
 
■ Yes       No 
 
14 Restart the perfusion system N/A 
15 End the timelapase capture N/A 
16 Revisit the same XY coordinates from step N. Image each of 
these locations 
N/A 
17 Shut off the perfusion system N/A 
18 With the stopwatch, time how long is required to disconnect 
the device from the microscope 
Total breakdown time: 
 
_5_ min _12__ sec 
 
Did the user have any dexterity-
related issues with device 
breakdown? 
 
 Yes      ■ No 
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Each of the rows below represents an XY coordinate of the microscope before and after the 
process of testing. They show completely different fields of view in each image, implying that the same 
section of the slide was not imaged, despite the microscope being commanded to image an identical XY 
coordinate. 
 
Before Testing After Testing 
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Appendix F: Verification Protocol Testing Used to Test the Low Fluid Alarm 
This verification protocol was followed and completed to test compliance with specification 002. 
Step User Instruction Documentation of Result 
1 With the perfusion in system off (valve in the perpendicular 
position), fill the control solution syringe with distilled water 
N/A 
2 Attach the low ringer alarm apparatus to the perfusion in 
syringe, with the float inserted directly into the chamber of 
the syringe 
Is the LED indicator on while the 
water level in the syringe is full? 
 
 Yes      ■ No 
 
3 Turn off the lights N/A 
4 Begin video recording of the syringe and LED N/A 
5 While recording, move the valve to the open position to 
allow fluid to flow out of the syringe 
N/A 
6 Continue recording as the water level lowers until either the 
LED turns on or all fluid has exited the syringe 
Does the LED indicator turn on 
some amount of time before the 
fluid in the perfusion in system is 
drained? 
 
■ Yes       No 
 
7 Stop the recording N/A 
8 Allow the perfusion system to fully drain N/A 
9 Remove the low ringer alarm apparatus N/A 
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Appendix G: Verification Testing Protocol Used to Determine Concentration of a 
Substance in the Slide Chamber as a Function of Perfusion Time 
This verification protocol was followed and completed to test compliance with specification 005. 
 
Step User Instruction Documentation of Result 
1 Prepare a serial dilution of 2X Bromophenol Blue ink in a 
series of nine cuvettes. These should contain the following 
percent concentrations of ink: 
 
17.50 % 
8.750 % 
4.375 % 
2.187 % 
1.093 % 
0.546 % 
0.273 % 
0.136 % 
0.068 % 
N/A 
2 Analyze these cuvettes by use of spectrophotometer, using a 
wavelength of 590 nm. Record the reported optical densities 
Percent 
Concentration 
Ink 
Optical 
Density 
17.5 
2.844 
38.75 
2.83 
4.375 
2.32 
2.1875 
1.202 
1.09375 
0.689 
0.546875 
0.363 
0.2734375 
0.201 
0.1367188 
0.139 
0.0683594 
0.1 
 
3 Fill the perfusion in syringe with distilled water N/A 
4 Set up the device with a blank, clean slide N/A 
5 Add 250 mL of 2X Bromophenol Blue ink into the culture dish N/A 
6 Turn on the perfusion out system to lower the level of blue 
ink down to a stable level 
N/A 
7 Obtain a stopwatch N/A 
8 Simultaneously begin the stopwatch and turn on the 
perfusion in system 
N/A 
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9 After four seconds, sample 15 mL8 of solution from the slide 
with a micropipette 
N/A 
10 Add this to a cuvette along with 985 µL distilled water N/A 
11 Repeat steps 5-10 two more times N/A 
12 Repeat steps 5-10, using a time of eight seconds instead of 
four seconds 
N/A 
13 Repeat steps 5-10, using a time of twelve seconds instead of 
four seconds 
N/A 
14 Repeat steps 5-10, using a time of sixteen seconds instead of 
four seconds 
N/A 
15 Repeat steps 5-10, using a time of zero seconds instead of 
four seconds 
N/A 
16 Analyze the obtained samples into a spectrophotometer, 
using a wavelength of 590 nm. Record the reported optical 
densities 
Time 
(sec) 
Trial 1 Trial 2 Trial 3 
0  0.751 0.728 0.659 
2 0.372 0.459 0.579 
4 0.422 0.429 0.633 
8 0.344 0.263 0.273 
12 0.102 0.143 0.120 
16 0.050 0.077 0.064 
 
17 Clean and replace all materials N/A 
18 Use the data to determine the average concentration in the 
slide as a function of time. Report the equation and R2 value 
which best describes the trend to the right. 
Equation:   y = 167.7e-0.285x 
R2 Value: 0.951 
 
 
Determination of the Relationship Between Concentration and Time 
 Below is listed the raw data of the standard curve, collected in step 2. 
 
Percent 
Concentration Ink Volume 
Water 
Volume 
Optical 
Density 
17.5 175.0 825.0 2.844 
8.75 87.5 912.5 2.83 
4.375 43.8 956.3 2.32 
2.1875 21.9 978.1 1.202 
1.09375 10.9 989.1 0.689 
0.546875 5.5 994.5 0.363 
0.2734375 2.7 997.3 0.201 
0.13671875 1.4 998.6 0.139 
0.068359375 0.7 999.3 0.1 
 
                                                          
8
 This value was determined to keep all optical densities below one, and was based on the results of step 2. UNG 
experimenters noted that the performance of the available spectrophotometer dropped significantly at values 
greater than one. 
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Only values with optical densities below 1.0 are used, due to concerns from UNG staff about the 
validity of the spectrophotometer above this level. 
 
 
 A linear relationship between optical density and percent concentration of ink is revealed. This 
relationship may be described by: 
 
               (      )  (                     )  (      ) 
 
or, alternatively 
                     
                     
      
 
 When applied to the collected time dependence data from the slide, we find the following 
 
Optical Density 
 Time Trial 1 Trial 2 Trial 3 Average 
0 1.21 1.17 1.05 1.143333333 
4 0.422 0.429 0.633 0.494666667 
8 0.344 0.263 0.273 0.293333333 
12 0.102 0.143 0.12 0.121666667 
16 0.05 0.077 0.064 0.063666667 
 
 
 
y = 0.5761x + 0.0543 
R² = 0.9989 
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Percent Concentration 
 Time Trial 1 Trial 2 Trial 3 Average 
0 2.006075334 1.936642944 1.728345773 1.890354684 
4 0.638257247 0.650407915 1.004513105 0.764392756 
8 0.502864086 0.362263496 0.379621593 0.414916392 
12 0.082798125 0.153966325 0.114042701 0.116935717 
16 -0.007463982 0.039402881 0.016837355 0.016258751 
 
However, these are the concentrations after 15 microliters extracted from the slide had been 
diluted in 985 additional microliters of fluid. Therefore, the true concentrations extracted from the slide 
may be found by multiplying these by the final volume of liquid (1mL) ny the original volume of liquid, 
15 microliters. 
 
 
Original Percent Concentration 
 Time Trial 1 Trial 2 Trial 3 Average 
0 133.7383556 129.1095296 115.2230516 126.0236456 
4 42.55048313 43.36052769 66.96754036 50.95951706 
8 33.52427241 24.15089973 25.30810623 27.66109279 
12 5.519875022 10.26442169 7.602846728 7.795714479 
16 -0.497598797 2.626858763 1.122490308 1.083916758 
 
 
 
  
y = 167.7e-0.285x 
R² = 0.951 
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Appendix H: Verification Protocol Testing the Consistency of Positions of the Inflow and 
Outflow  
This verification protocol was followed and completed to test compliance with specification 014. 
 
Step User Instruction Documentation of Result 
1 Using calipers, measure the distance between the tips of the 
micropipettes used in the perfusion in and out systems 
Distance: 
_____15.85______mm 
2 Vigorously shake the device N/A 
3 Using calipers, measure the distance between the tips of the 
micropipettes used in the perfusion in and out systems 
Distance: 
____15.64______mm 
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Appendix I: Verification Protocol Testing for Compatibility with the Thermal Control Setup 
This verification protocol was followed and completed to test compliance with specification 015. 
 
Step User Instruction Documentation of Result 
1 Connect the two thermal control plug-ins to the sides of the 
thermal control ring 
N/A 
2 Insert the thermal control ring into the microscope N/A 
3 Place the device flush on top of the thermal control ring, as in 
typical imaging 
Are there any mechanical 
interferences which would cause 
a reduction in imaging 
capability? 
 
 Yes      ■ No 
 
4 Record this position by camera N/A 
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Appendix J: Verification Protocol Testing the Consistency of Fluid Volume in the Slide 
Chamber 
This verification protocol was followed and completed to test compliance with specification 004. 
 
Step User Instruction Documentation of Result 
1 Set up the device, with the perfusion in systems and 
perfusion off systems both disabled 
N/A 
2 Using a micropipette, fill the slide area with at least 1 mL of 
distilled water 
N/A 
3 Turn on the perfusion out pump. Wait for the level of fluid in 
over the slide to stabilize 
N/A 
4 Turn off the perfusion out pump N/A 
5 Using a micropipette, remove all remaining liquid from the 
slide. Note how much fluid was removed. 
Removed Volume1: 240 µL 
6 Repeat steps 2-5 an additional nine times Removed Volume2: 230 µL 
Removed Volume3: 240 µL 
Removed Volume4: 250 µL 
Removed Volume5: 230 µL 
Removed Volume6: 240 µL 
Removed Volume7: 240 µL 
Removed Volume8: 190 µL 
Removed Volume9: 190 µL 
Removed Volume10: 190 µL 
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Appendix K: Verification Testing the Effectiveness of the Light Shield 
This verification protocol was followed and completed to test compliance with specification 008. 
 
Step User Instruction Documentation of Result 
1 Set up the microscope for fluorescent imaging N/A 
2 Place a slide containing only distilled water into the slide 
holder and insert it into the microscope 
N/A 
3 Turn off the room lights N/A 
4 With neither the box nor the device blocking light from the 
slide, collect two 15 second trials of fluorescence imaging 
data. 
Two stacks of images should be 
saved 
5 With the box from the prior UNG setup blocking light from  
the slide, collect two 15 second trials of fluorescence imaging 
data 
Two stacks of images should be 
saved 
6 With the device from the prior UNG setup blocking light from  
the slide, collect two 15 second trials of fluorescence imaging 
data 
Two stacks of images should be 
saved 
7 For each of the six collected stacks of images, use the 
microscope Region of Interest tool to calculate the average 
intensities as a function of time of the entire field of view 
Six text files containing the 
record of intensity as a function 
of time should be saved 
8 Offload these data files from the microscope computer N/A 
9 Remove and dispose of the slide used N/A 
10 
 
Analyze the results Analysis below 
 
 Each of the trials of light intensity as a function of time is plotted below. 
 
Figure 48- Verification testing of the light shield performance. Each line represents one trial tracking intensity as a function of 
time 
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It can be seen from this data that while an unblocked system clearly allows more light into the 
system than the light shield or the box, it is difficult to compare the efficiency of the box as compared to 
the efficiency of the light shield. A bar chart, which combines the two trials for each condition, 
underscores this difficulty. 
 
 
Figure 49- The light blocking performance of the device. Error bars are +/- 1 standard deviation about the mean. It can be 
seen that the device clearly outperforms an unshielded system, but demonstrates no significant difference in light-blocking 
performance as compared to the box 
 
It is concluded that while it is unclear whether the device represents a significant improvement in light 
blocking over the box previously used, it at least does no worse than the box, and performs significantly 
better than an unshielded microscope. 
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Appendix L: Standard Operating Procedure for Insertion of a Slide into the Slide 
Chamber 
 This standard operating procedure describes the method by which a cell-covered slide should be 
inserted into the slide chamber 
Materials 
 Sterilized tweezers 
 Ringer’s Solution 
 Mounting plate (bottom half of the slide chamber) 
 
Mounting Cells 
1. Carefully, using sterile tweezers, lift the slide of stained cells and place into mounting plate 
2. Firmly press the top half of the slide chamber down over the top of the slide 
3. Add Ringer’s Solution to the edges of the slide 
Note: Add Ringer’s Solution slowly (drop wise), and not directly to the cells. This will prevent 
cells from either washing out or detaching  
 XXI 
  
Appendix M: Standard Operating Procedure for Breakdown of the Olympus Microscope 
 This operating procedure contains all steps to follow in order to return the microscopy setup to 
its idle state 
Procedure: 
1. Run distilled water through the perfusion inflow tubing system to rinse out the system 
2. Add distilled water into the slide chamber. Suck up this water with the perfusion outflow system 
3. Turn off the pump 
4. Disconnect the perfusion inflow and outflow tubing from the device 
5. Remove the device and thermal control ring 
6. Remove the slide from the slide chamber. Dispose of in a biohazard container if appropriate 
7. If any part of the microscope setup is wet, remove the napkin that surrounds the objective lens 
and replace this napkin 
8. Turn off the camera 
9. Turn off Xenon lamp. Leave a note near the on/off switch indicating at what time the lamp was 
turned off 
10. Log off of the computer 
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Appendix N: MATLAB Script used for Data Analysis and Presentation 
 Below is documented the MATLAB 2013A function which was used to process data produced by 
the SlideBook5 software. 
% function calciumtraces.m 
% Script to read and plot data of individual folders containing .txt files 
% intensity data for non-ratiometric dyes 
% 
% Edit the Foldercontents variable to select more specific files  
clear all; close all; 
  
Foldercontents = dir('*.txt');          % ALTERABLE: read filenames to struc 
  
set(0,'DefaultAxesXGrid','on');         % set some default plot parameters 
set(0,'DefaultAxesYGrid','off'); 
axismaximum=0;                          % counters for plotting 
NumFiles = length(Foldercontents);      % number of files 
for D=1:length(Foldercontents);         % for each file 
    filename = Foldercontents(D).name;  % get filename from dir struc 
    fid = fopen(filename,'r');          % open text file 
    firstline=fgetl(fid);               % get first Line 
    titlestring(D)={firstline(13:end)}; % extract file title 
    currLine=1;                         % set counter for current line 
    while currLine<=5                   % skip  5 lines of header 
        firstline=fgetl(fid); 
        currLine = currLine + 1; 
    end 
    numcols=sum(isspace(firstline));    % How many ROIs are there? 
    if D==1                             % set color scheme for plotting 
        colors=rand((numcols),3); 
    end 
    textformat = repmat('%s ',1,numcols); 
    data = textscan(fid,textformat);    % Scan in data columns 
    fclose(fid);                        % close text file 
     
    % -------------- Now just Raw data-------------- 
     
    time = data{(3)};                   % time, third data column 
    time = cell2mat(cellfun(@str2num, time, 'UniformOutput', false)); 
    figure     
    for i = 4:numcols                   % for the rest columns 
        templine = data{(i)};           % cell array data to arrays 
        templine = cell2mat(cellfun(@str2num, templine, 'UniformOutput', false)); 
        f0=templine(1);                 % set prelim f0 value 
        for j=2:length(templine)-1      % for each value in Line 
            newline(j-1)=(templine(j)-f0)/f0; % normalize  
            if f0 > templine(j-1)       % find global min so far 
                if f0 > templine(j+1) 
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                        f0 = templine(j); 
                end 
            end 
        end 
        fmax=max(newline);              % set max & min for plotting 
        fmin=min(newline); 
        if fmax > axismaximum 
            axismaximum=fmax; 
        end 
        time=(time(1:end-2)./1000)';    % fit time vector to plot 
        hPlot=plot(time,newline);       % plot handle 
        set(hPlot,'Color',colors(i,:)); 
        set(hPlot,'LineWidth',1) 
        hold on    
    end 
  
  
    hTitle=title(titlestring{D});        % Set plot settings 
    hXLabel=xlabel('Time (seconds)'); 
    hYLabel=ylabel('Normalized Intensity (Arbitrary Units)'); 
    xlim([0 max(time-1)]) 
    set([hTitle, hXLabel, hYLabel], ... 
        'FontName'   , 'AvantGarde'); 
    set([hXLabel, hYLabel]  , ... 
        'FontSize'   , 12      ,... 
        'FontWeight' , 'bold'      ); 
    set( hTitle                    , ... 
        'FontSize'   , 14          , ... 
        'FontWeight' , 'bold'      ); 
    clearvars -except... 
        Foldercontents D NumFiles axismaximum titlestring colors 
end 
  
for k=1:NumFiles 
    h_ax=gca(figure(k));                % for each plot 
    ylim([0 axismaximum]);              % set the axis 
    print('-dtiff',[titlestring{k} '.tif']) 
end 
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Appendix O: Standard Operating Procedure for the Production of Ringer’s Solution 
Ringer’s Solution is a clear solution, which mirrors the concentrations of major ions and sugars 
in brain fluid. It is perfused over cells during neuron microscopy in order to keep the cells alive. 
 
Chemicals 
o NaCl 
o KCl 
o CaCl2 
o MgCl2 
o Glucose 
o Hepes 
o NaOH 
Materials 
o A 500mL volumetric flask 
o A 500mL beaker 
o Digital pH meter 
o Stirrer plate and stirrer 
o Micropipettes 
 
Table 9- Ingredients for 500mL Final Volume of Ringer's Solution 
Material Final Concentration (mM) Measurements (mL) 
NaCl 145 14.5mL 
KCl 3 1.5mL 
CaCl2 1.5 0.75mL 
MgCl2 1 0.5mL 
Glucose 10 0.9g 
Hepes 10 5mL 
 
Based on desired final concentration and volume, a certain volume of each stock solution should 
be added to the sterile 500mL beaker. This volume may be calculated for each solution according to the 
following equation. 
 
                     
(                   )  (            )
(                               )
 
Procedure: 
1. Add de-ionized water to the 500mL beaker until it is approximately filled to the final desired 
volume 
2. Place beaker onto a stirrer plate and add in a stirrer rod. Begin mixing the solution 
3. Add ingredients into de-ionized water 
4. Cover solution with parafilm to transfer  
5. Calibrate the pH meter 
a. Turn on calibration device. Wait. 
b. Remove cap from electrode and rinse gently with de-ionized water, catch waste in 
100mL beaker 
c. Press “CAL” then set Buffer 1 to pH 10.00 using the “^ °C” button 
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d. Submerge electrode in falcon tube of 10pH buffer solution. Wait until calibration is 
calculated. 
e. Remove electrode from buffer 10, rinse with de-ionized water, gently dap the electrode 
tip to dry 
f. Set buffer 2 to pH 7.00 
g. Insert electrode into 7pH buffer solution and wait until calibrated 
h. Press “CAL”  
i. Rinse off electrode tip with de-ionized water and place into Ringer’s solution 
j. Put on safety goggles before dealing with the 2M NaOH  
6. Using a micropipette, add drops of NaOH until the pH meter indicates that an acidity of 7.4 has 
been reached 
7. Transfer the solution to a volumetric flask 
8. Seal the top of the volumetric flask with Parafilm 
9. Wash and replace all materials 
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Appendix P: Standard Operating Procedure for Production of Complete Neuron Medium  
 Complete neuron medium is a combination of simple neuron medium and fetal bovine serum 
(FBS). It is used for the long-term storage of hippocampal neuron cells. 
Materials: 
1. Syringe 
2. Pore size .22 micron filter  
3. 2 x Falcon Tube 
 
Chemicals and Measurements: 
1. Neuron Medium 
5mL per one large (100 x 15 mm) Petri dish  
2. FBS serum 
10% of total volume  
3. ARA-C Glial Inhibitor  
1:3000 of ARA-C: Medium  
 
Procedure: 
1. Add neuron medium to Falcon tube with auto-pipette 
2. Add FBS serum to same Falcon tube with auto-pipette 
3. Using pore size .22 filter and syringe, filter the new medium 
a. Attach filter to empty falcon tube  
b. Add in small amounts of new medium 
c. Push through filter with plunger 
4. Once filtered, we add ARA-C glial inhibitor  
5. Label: Date, “Complete Neuron Medium, 10% Serum” 
6. Refrigerate the solution 
7. Clean the biological hood 
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Appendix Q: Standard Operating Procedure for Changing of Cell Medium 
 To ensure long-term hippocampal neuron health, the medium in their petri dish needs to be 
changed every three days. Below is listed the procedure for this process. 
 
Chemicals: 
1. Neuron Medium  
a. 3mL per one large Petri dish 
2. FBS Serum 
a. 5% of total volume 
3. Waste beaker 
4. 5mL auto-pipette 
 
Procedure: 
1. Remove medium and FBS serum for refrigerator and bring to room temperature 
2. Calculate amount of medium and FBS serum needed 
a. (3mL * # of Petri dishes = total volume) 
b. (0.05 * total volume = FBS volume) 
c. (total volume – FBS volume =neuron medium volume) 
3. Add neuron medium to empty falcon tube 
4. Add FBS serum to falcon tube with medium 
5. Remove cell plates from incubator 
6. Slowly remove 2.5 mL (of half) of the medium in the cell Petri using a 5mL auto-pipette and 
dispose into waste beaker 
a. Note: gently insert pipette at edge of Petri and suction slowly 
7. Add 2.5mL of new medium to each plate 
a. Note: ass SLOWLY to edge of plate without touching tip of pipette to the current 
medium 
8. Cover Petri dishes and place back in incubator carefully as not to dislodge cells from glass plates 
9. Replace original neuron medium and FBS serum to the refrigerator 
10. Clean the biological hood 
